O-I Glass (OI) 10-Q 24 Oct 17 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information	9 Months Ended
	Sep. 30, 2017shares
Document and Entity Information
Entity Registrant Name	OWENS ILLINOIS INC /DE/
Entity Central Index Key	812,074
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	162,990,974
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3

CONDENSED CONSOLIDATED RESULTS

CONDENSED CONSOLIDATED RESULTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
CONDENSED CONSOLIDATED RESULTS OF OPERATIONS
Net sales	$ 1,791	$ 1,712	$ 5,157	$ 5,060
Cost of goods sold	(1,438)	(1,376)	(4,143)	(4,063)
Gross profit	353	336	1,014	997
Selling and administrative expense	(120)	(121)	(362)	(375)
Research, development and engineering expense	(15)	(16)	(46)	(48)
Interest expense, net	(63)	(66)	(204)	(199)
Equity earnings	22	15	55	44
Other expense, net	(5)	5	(61)	(24)
Earnings from continuing operations before income taxes	172	153	396	395
Provision for income taxes	(37)	(36)	(65)	(93)
Earnings from continuing operations	135	117	331	302
Loss from discontinued operations	(2)	(3)	(2)	(6)
Net earnings	133	114	329	296
Net earnings attributable to noncontrolling interests	(7)	(6)	(15)	(16)
Net earnings attributable to the Company	126	108	314	280
Amounts attributable to the Company:
Earnings from continuing operations	128	111	316	286
Loss from discontinued operations	(2)	(3)	(2)	(6)
Net earnings attributable to the Company	$ 126	$ 108	$ 314	$ 280
Basic earnings per share:
Earnings from continuing operations (in dollars per share)	$ 0.78	$ 0.68	$ 1.94	$ 1.76
Loss from discontinued operations (in dollars per share)	(0.01)	(0.02)	(0.01)	(0.04)
Net earnings (in dollars per share)	$ 0.77	$ 0.66	$ 1.93	$ 1.72
Weighted average shares outstanding (thousands) (in shares)	162,866	162,080	162,658	161,744
Diluted earnings per share:
Earnings from continuing operations (in dollars per share)	$ 0.77	$ 0.68	$ 1.92	$ 1.75
Loss from discontinued operations (in dollars per share)	(0.01)	(0.02)	(0.01)	(0.04)
Net earnings (in dollars per share)	$ 0.76	$ 0.66	$ 1.91	$ 1.71
Weighted average diluted shares outstanding (thousands) (in shares)	164,993	163,204	164,440	162,607

CONDENSED CONSOLIDATED COMPREHE

CONDENSED CONSOLIDATED COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
CONDENSED CONSOLIDATED COMPREHENSIVE INCOME
Net earnings	$ 133	$ 114	$ 329	$ 296
Other comprehensive income (loss):
Foreign currency translation adjustments	10	(79)	212	(93)
Pension and other postretirement benefit adjustments, net of tax	10	21	25	5
Change in fair value of derivative instruments, net of tax		(1)	(10)	5
Other comprehensive income (loss)	20	(59)	227	(83)
Total comprehensive income	153	55	556	213
Comprehensive income attributable to noncontrolling interests	(8)	(4)	(8)	(6)
Comprehensive income attributable to the Company	$ 145	$ 51	$ 548	$ 207

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2017	Jun. 30, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 339		$ 492	$ 294
Trade receivables, net of allowance of $36 million, $32 million, and $32 million at September 30, 2017, December 31, 2016 and September 30, 2016	1,028		580	857
Inventories	1,046		983	1,057
Prepaid expenses and other current assets	254		199	234
Total current assets	2,667		2,254	2,442
Property, plant and equipment, net	3,036		2,880	2,917
Goodwill	2,621		2,462	2,534
Intangibles, net	473		464	490
Other assets	1,202		1,075	1,114
Total assets	9,999		9,135	9,497
Current liabilities:
Short-term loans and long-term debt due within one year	243		195	262
Current portion of asbestos-related liabilities	115		115	130
Accounts payable	1,087		1,135	1,059
Other liabilities	617		615	582
Other liabilities - discontinued operations	115
Total current liabilities	2,177		2,060	2,033
Long-term debt	5,378		5,133	5,333
Asbestos-related liabilities	528		577	643
Other long-term liabilities	977		1,002	973
Share owners' equity	939	$ 779	363	515	$ 458	$ 279
Total liabilities and share owners' equity	$ 9,999		$ 9,135	$ 9,497

CONDENSED CONSOLIDATED BALANCE5

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016
CONSOLIDATED BALANCE SHEETS
Trade receivables allowance	$ 36	$ 32	$ 32

CONDENSED CONSOLIDATED CASH FLO

CONDENSED CONSOLIDATED CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net earnings	$ 329	$ 296
Loss from discontinued operations	2	6
Non-cash charges
Depreciation and amortization	372	372
Pension expense	22	22
Restructuring, asset impairment and related charges	48	19
Cash payments
Pension contributions	(28)	(15)
Asbestos-related payments	(49)	(45)
Cash paid for restructuring activities	(30)	(20)
Change in components of working capital	(601)	(320)
Other, net (a)	(26)	(89)
Cash provided by continuing operating activities	39	226
Cash utilized in discontinued operating activities	(2)	(6)
Total cash provided by operating activities	37	220
Cash flows from investing activities:
Additions to property, plant and equipment	(292)	(310)
Acquisitions, net of cash acquired	(37)	(45)
Net cash proceeds related to sale of assets	14	57
Net foreign exchange derivative activity		16
Cash utilized in continuing investing activities	(315)	(282)
Cash provided by discontinued investing activities	115
Total cash utilized in investing activities	(200)	(282)
Cash flows from financing activities:
Changes in borrowings, net	23	(31)
Issuance of common stock and other	(5)	5
Distributions to noncontrolling interests	(9)	(10)
Payment of finance fees	(23)	(3)
Cash utilized in financing activities	(14)	(39)
Effect of exchange rate fluctuations on cash	24	(4)
Decrease in cash	(153)	(105)
Cash at beginning of period	492	399
Cash at end of period	$ 339	$ 294

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2017
Segment Information
Segment Information	1. Segment Information The Company has four reportable segments based on its geographic locations: Europe, North America, Latin America and Asia Pacific. These four segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations. Certain assets and activities not directly related to one of the regions or to glass manufacturing are reported with Retained corporate costs and other. These include licensing, equipment manufacturing, global engineering, and certain equity investments. Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments. The Company’s measure of profit for its reportable segments is segment operating profit, which consists of consolidated earnings from continuing operations before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations as well as certain retained corporate costs. The Company’s management uses segment operating profit, in combination with net sales and selected cash flow information, to evaluate performance and to allocate resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided. Intercompany sales in Latin America totaled $34 million and $97 million for the three and nine months ended September 30, 2017, respectively, and $36 million and $129 million for the three and nine months ended September 30, 2016, respectively. Financial information for the three and nine months ended September 30, 2017 and 2016 regarding the Company’s reportable segments is as follows: Three months ended September 30, Nine months ended September 30, 2017 2016 2017 2016 Net sales: Europe $ 624 $ 586 $ 1,813 $ 1,795 North America 551 578 1,651 1,709 Latin America 412 365 1,123 1,022 Asia Pacific 188 170 516 487 Reportable segment totals 1,775 1,699 5,103 5,013 Other 16 13 54 47 Net sales $ 1,791 $ 1,712 $ 5,157 $ 5,060 Three months ended September 30, Nine months ended September 30, 2017 2016 2017 2016 Segment operating profit: Europe $ 81 $ 64 $ 220 $ 192 North America 75 79 252 247 Latin America 84 74 207 194 Asia Pacific 20 20 51 48 Reportable segment totals 260 237 730 681 Items excluded from segment operating profit: Retained corporate costs and other (25) (18) (81) (75) Restructuring, asset impairment and other (49) (12) Interest expense, net (63) (66) (204) (199) Earnings from continuing operations before income taxes $ 172 $ 153 $ 396 $ 395 Financial information regarding the Company’s total assets is as follows: September 30, December 31, September 30, 2017 2016 2016 Total assets: Europe $ 3,140 $ 2,792 $ 2,972 North America 2,826 2,522 2,536 Latin America 2,772 2,537 2,629 Asia Pacific 1,046 926 1,025 Reportable segment totals 9,784 8,777 9,162 Other 215 358 335 Consolidated totals $ 9,999 $ 9,135 $ 9,497

Inventories

Inventories	9 Months Ended
	Sep. 30, 2017
Inventories
Inventories	2. Inventories Major classes of inventory at September 30, 2017, December 31, 2016 and September 30, 2016 are as follows: September 30, December 31, September 30, 2017 2016 2016 Finished goods $ 875 $ 827 $ 892 Raw materials 129 118 127 Operating supplies 42 38 38 $ 1,046 $ 983 $ 1,057

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets	9 Months Ended
	Sep. 30, 2017
Prepaid Expenses and Other Current Assets
Prepaid Expenses and Other Current Assets	3. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets at September 30, 2017, December 31, 2016 and September 30, 2016 are as follows: September 30, December 31, September 30, 2017 2016 2016 Prepaid expenses $ 50 $ 50 $ 61 Value added taxes 44 46 42 Other 160 103 131 $ 254 $ 199 $ 234

Derivative Instruments

Derivative Instruments	9 Months Ended
	Sep. 30, 2017
Derivative Instruments
Derivative Instruments	4. Derivative Instruments The Company has certain derivative assets and liabilities which consist of natural gas forwards and foreign exchange option and forward contracts. The Company uses an income approach to value these contracts. Natural gas forward rates and foreign exchange rates are the significant inputs into the valuation models. These inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. The Company also evaluates counterparty risk in determining fair values. Commodity Forward Contracts Designated as Cash Flow Hedges In several regions, the Company enters into commodity forward contracts related to forecasted natural gas requirements, the objectives of which are to limit the effects of fluctuations in the future market price paid for natural gas and the related volatility in cash flows. In North America, the majority of its customer contracts contain provisions that pass the price of natural gas to its customers. In certain of these contracts, the customer has the option of fixing the natural gas price component for a specified period of time. To limit the effects of fluctuations in cash flows resulting from these customer contracts, the Company enters into commodity forward contracts related to forecasted natural gas requirements. In Asia Pacific, the Company implemented a hedging program in the first quarter of 2016, which included the execution of commodity forward contracts for certain contracted natural gas requirements. At September 30, 2017 and 2016, the Company had entered into commodity forward contracts covering approximately 9,300,000 MM BTUs and 12,400,000 MM BTUs, respectively. The Company accounts for the above forward contracts as cash flow hedges at September 30, 2017 and recognizes them on the balance sheet at fair value. The effective portion of changes in the fair value of a derivative that is designated as, and meets the required criteria for, a cash flow hedge is recorded in the Accumulated Other Comprehensive Income component of share owners’ equity (“OCI”) and reclassified into earnings in the same period or periods during which the underlying hedged item affects earnings. An unrecognized loss of less than $1 million at September 30, 2017, an unrecognized gain of $6 million at December 31, 2016 and an unrecognized gain of $2 million at September 30, 2016 related to the commodity forward contracts was included in Accumulated OCI, and will be reclassified into earnings in the period when the commodity forward contracts expire. Any material portion of the change in the fair value of a derivative designated as a cash flow hedge that is deemed to be ineffective is recognized in current earnings. The ineffectiveness related to these natural gas hedges for the three and nine months ended September 30, 2017 and 2016 was not material. The effect of the commodity forward contracts on the results of operations for the three months ended September 30, 2017 and 2016 is as follows: Amount of Gain (Loss) Reclassified from Amount of (Loss) Recognized in OCI on Accumulated OCI into Income Commodity Forward Contracts (reported in cost of goods sold) (Effective Portion) (Effective Portion) 2017 2016 2017 2016 $ (1) $ (1) $ — $ — The effect of the commodity forward contracts on the results of operations for the nine months ended September 30, 2017 and 2016 is as follows: Amount of Gain (Loss) Reclassified from Amount of Gain Recognized in OCI on Accumulated OCI into Income Commodity Forward Contracts (reported in cost of goods sold) (Effective Portion) (Effective Portion) 2017 2016 2017 2016 $ 3 $ 2 $ — $ — Foreign Exchange Derivative Contracts and not Designated as Hedging Instruments The Company may enter into short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. The Company may also use foreign exchange agreements to offset the foreign currency risk for receivables and payables, including intercompany receivables, payables, and loans, not denominated in, or indexed to, their functional currencies. The Company records these short-term foreign exchange agreements on the balance sheet at fair value and changes in the fair value are recognized in current earnings. At September 30, 2017 and 2016, the Company had outstanding foreign exchange and option agreements denominated in various currencies covering the equivalent of approximately $320 million and $580 million, respectively, related primarily to intercompany transactions and loans. The effect of the foreign exchange derivative contracts on the results of operations for the three months ended September 30, 2017 and 2016 is as follows: Amount of Gain (Loss) Location of Gain (Loss) Recognized in Income on Recognized in Income on Foreign Exchange Contracts Foreign Exchange Contracts 2017 2016 Other expense $ (2) $ 4 The effect of the foreign exchange derivative contracts on the results of operations for the nine months ended September 30, 2017 and 2016 is as follows: Amount of Gain Location of Gain Recognized in Income on Recognized in Income on Foreign Exchange Contracts Foreign Exchange Contracts 2017 2016 Other expense $ 4 $ 6 Hedges of Multiple Risks The Company has variable-interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in both the underlying variable interest rate and the currency of the borrowing against the subsidiaries’ functional currency. The Company uses derivatives to manage these exposures and designates these derivatives as cash flow hedges of both interest rate and foreign exchange risks. The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges of both interest rate risk and foreign exchange risk is recorded in Accumulated OCI and is subsequently reclassified into earnings in the period for which the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivative is recognized directly in earnings. During the second quarter of 2017, one of the Company’s Euro-functional subsidiaries entered into a cross-currency interest rate swap to manage its exposure to fluctuations in the variable interest rate and the U.S. dollar-Euro exchange rate arising from a U.S. dollar denominated borrowing. This swap involves exchanging fixed rate Euro interest payments for floating rate U.S. dollar interest receipts both of which will occur at the forward exchange rates in effect upon entering into the instrument. This instrument, which settled in the third quarter of 2017, had a pay fixed notional amount of €81 million and a receive notional amount of $90 million. Interest Rate Swaps Designated as Fair Value Hedges In the third quarter of 2017, the Company entered into a series of interest rate swap agreements with a total notional amount of €400 million that reach final maturity in 2024. The swaps were executed in order to maintain a capital structure containing appropriate amounts of fixed and floating-rate debt. The Company’s fixed-to-variable interest rate swaps were accounted for as fair value hedges. The relevant terms of the swap agreements match the corresponding terms of the notes and therefore there is no hedge ineffectiveness. The Company recorded the net of the fair market values of the swaps as a long-term liability and short-term asset along with a corresponding net decrease in the carrying value of the hedged debt. Under the swaps, the Company receives fixed rate interest amounts (equal to the interest on the corresponding hedged note) and pays interest at a six-month Euribor rate (set in arrears) plus a margin spread (see table below). The interest rate differential on each swap is recognized as an adjustment of interest expense during each six-month period over the term of the agreement. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. The Company has determined that the majority of the inputs used to value these derivatives fall within Level 2 of the fair value hierarchy. The following selected information relates to fair value swaps at September 30, 2017: Amount Hedged Receive Rate Average Spread Senior Notes due 2024 € 400 3.125 % 2.5 % Balance Sheet Classification The Company records the fair values of derivative financial instruments on the balance sheet as follows: (a) receivables if the instrument has a positive fair value and maturity within one year, (b) deposits, receivables, and other assets if the instrument has a positive fair value and maturity after one year, (c) other accrued liabilities or other liabilities (current) if the instrument has a negative fair value and maturity within one year, and (d) other accrued liabilities or other liabilities if the instrument has a negative fair value and maturity after one year. The following table shows the amount and classification (as noted above) of the Company’s derivatives at September 30, 2017, December 31, 2016 and September 30, 2016: Fair Value Balance Sheet September 30, December 31, September 30, Location 2017 2016 2016 Asset derivatives: Derivatives designated as hedging instruments: Commodity futures contracts b $ 1 $ 6 $ 2 Interest rate swaps designated as fair value hedges a 2 Derivatives not designated as hedging instruments: Foreign exchange derivative contracts a 2 9 8 Total asset derivatives $ 5 $ 15 $ 10 Liability derivatives: Derivatives designated as hedging instruments: Commodity futures contracts c $ 1 $ — $ — Interest rate swaps designated as fair value hedges d 5 Derivatives not designated as hedging instruments: Foreign exchange derivative contracts c 3 5 2 Total liability derivatives $ 9 $ 5 $ 2

Restructuring Accruals

Restructuring Accruals	9 Months Ended
	Sep. 30, 2017
Restructuring Accruals
Restructuring Accruals	5. Restructuring Accruals Selected information related to the restructuring accruals for the three months ended September 30, 2017 and 2016 is as follows: Other Restructuring Actions Balance at July 1, 2017 $ 111 Net cash paid, principally severance and related benefits (14) Other, including foreign exchange translation 1 Balance at September 30, 2017 $ Other Asia Pacific Restructuring Total Restructuring Actions Restructuring Balance at July 1, 2016 $ 6 $ 28 $ 34 Net cash paid, principally severance and related benefits (1) (2) Other, including foreign exchange translation (2) Balance at September 30, 2016 $ 5 $ 24 $ 29 Selected information related to the restructuring accruals for the nine months ended September 30, 2017 and 2016 is as follows: Other Restructuring Actions Balance at January 1, 2017 $ 85 Charges Write-down of assets to net realizable value Net cash paid, principally severance and related benefits Other, including foreign exchange translation Balance at September 30, 2017 $ Other Asia Pacific Restructuring Total Restructuring Actions Restructuring Balance at January 1, 2016 $ 7 $ 36 $ 43 Charges 19 Write-down of assets to net realizable value (7) Net cash paid, principally severance and related benefits (20) Other, including foreign exchange translation (6) Balance at September 30, 2016 $ 5 $ 24 $ 29 The Company’s decisions to curtail selected production capacity have resulted in write downs of certain long-lived assets to the extent their carrying amounts exceeded fair value or fair value less cost to sell. The Company classified the significant assumptions used to determine the fair value of the impaired assets, which was not material, as Level 3 in the fair value hierarchy as set forth in the general accounting principles for fair value measurements. When a decision is made to take these actions, the Company manages and accounts for them separately from the on-going operations of the business. Information related to major programs (as in the case of the Asia Pacific Restructuring program above) are presented separately. Minor initiatives and discrete restructuring actions are presented on a combined basis as Other Restructuring Actions. When charges related to major programs are completed, remaining accrual balances are classified within Other Restructuring Actions. Asia Pacific Restructuring During the nine months ended September 30, 2016, the Company recorded charges of $1 million. These charges primarily represented other exit costs as part of the Company’s Asia Pacific Restructuring program. The Company recorded total cumulative charges of $224 million and does not expect to execute any further actions under this program. The Company expects that the majority of the remaining cash expenditures related to the above charges will be paid out by the end of 2018. Beginning in 2017, the Asia Pacific Restructuring program was considered substantially complete and the remaining accrual balance was reclassified into Other Restructuring Actions. Other Restructuring Actions During the three and nine months ended September 30, 2017, the Company recorded restructuring, asset impairment and other charges of $0 million and $48 million, respectively. For the nine months ended September 30, 2017, these charges primarily consist of employee costs, write-down of assets, and other exit costs in the following regions: Latin America ($33 million), Europe ($13 million) and North America ($2 million). Except for the charges recorded in Europe, the other discrete restructuring charges recorded in 2017 are expected to approximate the total cumulative costs for those actions as no significant additional costs are expected to be incurred. The Company has recorded total cumulative charges of $54 million related to a plant closure in Europe and does not expect to execute any further significant actions related to this facility. The restructuring charges recorded in 2017 in the Latin American and European regions primarily relate to capacity curtailments and products produced at those facilities have, in large part, been reallocated to others in their respective regions. The Company expects that the majority of the remaining cash expenditures related to the above charges will be paid out by the end of 2018. During the three and nine months ended September 30, 2016, the Company recorded restructuring, asset impairment and other charges of $0 and $18 million, respectively. These charges were primarily related to restructuring in the Latin America region. These charges primarily represented employee costs, write-down of assets, and other exit costs of $14 million for a plant closure in the first quarter of 2016 in Latin America, $3 million related to a previous plant closure in North America and $1 million related to other restructuring actions. The discrete restructuring charges recorded in the first quarter of 2016 are expected to approximate the total cumulative costs for those actions as no significant additional costs are expected to be incurred. The restructuring charges recorded in the first quarter of 2016 in the Latin American region primarily relate to a capacity curtailment. The Company reallocated the products produced at this facility to others in the region. The Company expects that the majority of the remaining cash expenditures related to the above charges will be paid out by the end of 2017.

Pension Benefit Plans

Pension Benefit Plans	9 Months Ended
	Sep. 30, 2017
Pension Benefit Plans.
Pension Benefit Plans	6. Pension Benefit Plans The components of the net periodic pension cost for the three months ended September 30, 2017 and 2016 are as follows: U.S. Non-U.S. 2017 2016 2017 2016 Service cost $ 4 $ 3 $ 4 $ 4 Interest cost 20 23 11 12 Expected asset return (33) (37) (18) (19) Amortization: Actuarial loss 14 16 5 5 Net periodic pension cost $ 5 $ 5 $ 2 $ 2 The components of the net periodic pension cost for the nine months ended September 30, 2017 and 2016 are as follows: U.S. Non-U.S. 2017 2016 2017 2016 Service cost $ 11 $ 11 $ 12 $ 13 Interest cost 59 72 33 38 Expected asset return (98) (113) (54) (61) Amortization: Actuarial loss 44 47 15 15 Net periodic pension cost $ 16 $ 17 $ 6 $ 5 In March 2016, the Company remeasured the liability related to its hourly plan in the U.S. to reflect certain changes in future benefits. The remeasurement resulted in an increase to its pension liability of approximately $60 million and has been reflected in other comprehensive income.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2017
Income Taxes
Income Taxes	7. Income Taxes The Company performs a quarterly review of the annual effective tax rate and makes changes if necessary based on new information or events. The estimated annual effective tax rate is forecasted quarterly using actual historical information and forward-looking estimates. The estimated annual effective tax rate may fluctuate due to changes in forecasted annual operating income; changes in the forecasted mix of earnings by country; changes to the valuation allowance for deferred tax assets (such changes would be recorded discretely in the quarter in which they occur); changes to actual or forecasted permanent book to tax differences (non-deductible expenses); impacts from future tax settlements with state, federal or foreign tax authorities (such changes would be recorded discretely in the quarter in which they occur); or impacts from tax law changes. To the extent such changes impact deferred tax assets/liabilities, these changes would generally be recorded discretely in the quarter in which they occur. Additionally, the annual effective tax rate differs from the statutory U.S. Federal tax rate of 35% primarily because of valuation allowances in some jurisdictions and varying non-U.S. tax rates, as well as the tax accruals reversed in the second quarter of 2017 due to the resolution of a previous tax matter with a foreign tax authority. The Company is currently under examination in various tax jurisdictions in which it operates, including Argentina, Bolivia, Brazil, China, Canada, Colombia, the Czech Republic, France, Germany, Indonesia, and Spain. The years under examination range from 2006 through 2015. The Company has received income tax assessments in excess of established reserves. The Company believes that adequate provisions for all income tax uncertainties have been made. However, if income tax assessments are settled against the Company at amounts in excess of established reserves, it could have a material impact to the Company’s results of operations, financial position or cash flows.

Debt

Debt	9 Months Ended
	Sep. 30, 2017
Debt
Debt	8. Debt The following table summarizes the long-term debt of the Company: September 30, December 31, September 30, 2017 2016 2016 Secured Credit Agreement: Revolving Credit Facility: Revolving Loans $ 200 $ — $ — Term Loans: Term Loan A 1,202 1,395 1,516 Term Loan A (€279 million) 308 282 303 Term Loan B 558 Senior Notes: 6.75%, due 2020 (€500 million) 586 523 557 4.875%, due 2021 (€330 million) 386 345 367 5.00%, due 2022 496 495 495 5.875%, due 2023 684 682 681 3.125%, due 2024 (€725 million at September 30, 2017 and €500 million at December 31, 2016) 840 520 6.375%, due 2025 295 294 294 5.375%, due 2025 297 297 296 Senior Debentures: 7.80%, due 2018 22 250 250 Capital Leases 54 57 62 Other 56 26 30 Total long-term debt 5,426 5,166 5,409 Less amounts due within one year 48 33 76 Long-term debt $ 5,378 $ 5,133 $ 5,333 On April 22, 2015, the Company entered into a Senior Secured Credit Facility, which subsequently has been amended several times with the most recent amendment being entered into on September 28, 2017 (the “Amended Agreement”). At September 30, 2017, the Amended Agreement includes a $300 million revolving credit facility, a $600 million multicurrency revolving credit facility, a $1,575 million term loan A facility ($1,202 million net of debt issuance costs), and a €279 million term loan A facility ($308 million net of debt issuance costs), each of which has a final maturity date of April 22, 2020. At September 30, 2017, the Company had unused credit of $652 million available under the Amended Agreement. The weighted average interest rate on borrowings outstanding under the Amended Agreement at September 30, 2017 was 2.57%. The Amended Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations. The Amended Agreement also contains one financial covenant, a Total Leverage Ratio that requires the Company not to exceed a ratio calculated by dividing consolidated total debt, less cash and cash equivalents (“Net Indebtedness”), by consolidated EBITDA, as defined in the Amended Agreement. The Total Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Total Leverage Ratio to exceed the specified maximum of (i) 4.5x for the fiscal quarter ending September 30, 2017, and (ii) 4.0x for the fourth fiscal quarter ending December 31, 2017 and each fiscal quarter thereafter. On September 28, 2017, the Company entered into Amendment No. 5 (“Amendment No. 5”) to the Amended Agreement. Amendment No. 5 changes the calculation of the Total Leverage Ratio by excluding from the calculation of Net Indebtedness ordinary course revolver borrowings (except to the extent such borrowings existed at the prior year end) and non-recourse factoring or securitization debt. Failure to comply with these covenants and restrictions could result in an event of default under the Amended Agreement. In such an event, the Company would be unable to request borrowings under the revolving facility, and all amounts outstanding under the Amended Agreement, together with accrued interest, could then be declared immediately due and payable. If an event of default occurs under the Amended Agreement and the lenders cause all of the outstanding debt obligations under the Amended Agreement to become due and payable, this would result in a default under a number of other outstanding debt securities and could lead to an acceleration of obligations related to these debt securities. As of September 30, 2017, the Company was in compliance with all covenants and restrictions in the Amended Agreement. In addition, the Company believes that it will remain in compliance and that its ability to borrow funds under the Amended Agreement will not be adversely affected by the covenants and restrictions. The interest rates on borrowings under the Amended Agreement are, at the Company’s option, the Base Rate or the Eurocurrency Rate, as defined in the Amended Agreement, plus an applicable margin. The applicable margin for the term loan A facility and the revolving credit facility is linked to the Company’s Total Leverage Ratio and ranges from 1.25% to 1.75% for Eurocurrency Rate loans and from 0.25% to 0.75% for Base Rate loans. In addition, a facility fee is payable on the revolving credit facility commitments ranging from 0.20% to 0.30% per annum linked to the Total Leverage Ratio. Borrowings under the Amended Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Borrowings are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign borrowings, of stock of certain foreign subsidiaries. All borrowings under the Amended Agreement are guaranteed by certain domestic subsidiaries of the Company. During August 2015, the Company issued senior notes with a face value of $700 million that bear interest at 5.875% and are due August 15, 2023 (the “Senior Notes due 2023”) and senior notes with a face value of $300 million that bear interest at 6.375% and are due August 15, 2025 (together with the Senior Notes due 2023, the “2015 Senior Notes”). The 2015 Senior Notes were issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds from the 2015 Senior Notes, after deducting the debt discount and debt issuance costs, totaled approximately $972 million. During November 2016, the Company issued senior notes with a face value of €500 million that bear interest at 3.125% and are due November 15, 2024 (the “Senior Notes due 2024”). The notes were issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds, after deducting debt issuance costs, totaled approximately $520 million and were used to repay the term loan B facility under the Amended Agreement. In March 2017, the Company expanded its borrowings under the Senior Notes due 2024 by issuing €225 million of additional notes that bear interest at 3.125% and are due November 15, 2024. The notes were issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds, after deducting debt issuance costs, totaled approximately $237 million and were used to repay a portion of the Company’s revolving credit facility. In March 2017, the Company purchased in a tender offer approximately $228 million aggregate principal amount of its 7.80% Senior Debentures due in 2018. Approximately $22 million of the Senior Debentures remain outstanding as of September 30, 2017. As part of the tender offer, the Company recorded $17 million of additional interest charges for note repurchase premiums and the related write-off of unamortized finance fees in the first quarter of 2017. The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market. The Company has a €185 million European accounts receivable securitization program, which extends through March 2019, subject to periodic renewal of backup credit lines. Information related to the Company’s accounts receivable securitization program is as follows: September 30, December 31, September 30, 2017 2016 2016 Balance (included in short-term loans) $ 170 $ 152 $ 158 Weighted average interest rate 0.65 % 0.74 % 0.67 % The carrying amounts reported for the accounts receivable securitization program, and certain long-term debt obligations subject to frequently redetermined interest rates, approximate fair value. Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations, and are classified as Level 1 in the fair value hierarchy. Fair values at September 30, 2017 of the Company’s significant fixed rate debt obligations are as follows: Principal Indicated Amount Market Price Fair Value Senior Notes: 6.75%, due 2020 (€500 million) $ 589 $ 118.38 $ 697 4.875%, due 2021 (€330 million) 389 113.85 443 5.00%, due 2022 500 105.80 529 5.875%, due 2023 700 110.65 775 3.125%, due 2024 (€725 million) 854 103.38 883 6.375%, due 2025 300 113.10 339 5.375%, due 2025 300 106.98 321 Senior Debentures: 7.80%, due 2018 22 103.77 23

Contingencies

Contingencies	9 Months Ended
	Sep. 30, 2017
Contingencies
Contingencies	9. Contingencies Asbestos The Company is a defendant in numerous lawsuits alleging bodily injury and death as a result of exposure to asbestos. From 1948 to 1958, one of the Company's former business units commercially produced and sold approximately $40 million of a high-temperature, calcium-silicate based insulation material containing asbestos. The Company sold its insulation business unit at the end of April 1958. The typical asbestos personal injury lawsuit alleges various theories of liability, including negligence, gross negligence and strict liability and seeks compensatory and, in some cases, punitive damages in various amounts (herein referred to as "asbestos claims"). As of September 30, 2017, the Company has determined that it is a named defendant in asbestos lawsuits and claims involving approximately 1,400 plaintiffs and claimants. Based on an analysis of the lawsuits pending as of December 31, 2016, approximately 88% of plaintiffs either do not specify the monetary damages sought, or in the case of court filings, claim an amount sufficient to invoke the jurisdictional minimum of the trial court. Approximately 9% of plaintiffs specifically plead damages above the jurisdictional minimum up to, and including, $15 million or less, and 3% of plaintiffs specifically plead damages greater than $15 million but less than or equal to $100 million. As indicated by the foregoing summary, current pleading practice permits considerable variation in the assertion of monetary damages. The Company’s experience resolving hundreds of thousands of asbestos claims and lawsuits over an extended period demonstrates that the monetary relief alleged in a complaint bears little relevance to a claim’s merits or disposition value. Rather, the amount potentially recoverable is determined by such factors as the type and severity of the plaintiff’s asbestos disease, the plaintiff’s medical history and exposure to other disease-causing agents, the product identification evidence against the Company and other co-defendants, the defenses available to the Company and other co-defendants, the specific jurisdiction in which the claim is made, and the plaintiff’s firm representing the claimant. In addition to the pending claims set forth above, the Company has claims-handling agreements in place with many plaintiffs’ counsel throughout the country. These agreements require evaluation and negotiation regarding whether particular claimants qualify under the criteria established by such agreements. The criteria for such claims include verification of a compensable illness and a reasonable probability of exposure to a product manufactured by the Company's former business unit during its manufacturing period ending in 1958. The Company has also been a defendant in other asbestos-related lawsuits or claims involving maritime workers, medical monitoring claimants, co-defendants and property damage claimants. Based upon its past experience, the Company believes that these categories of lawsuits and claims will not involve any material liability and they are not included in the above description of pending matters or in the following description of disposed matters. Since receiving its first asbestos claim, the Company as of September 30, 2017, has disposed of asbestos claims of approximately 399,000 plaintiffs and claimants at an average indemnity payment per claim of approximately $9,500. The Company’s asbestos indemnity payments have varied on a per claim basis, and are expected to continue to vary considerably over time. Asbestos-related cash payments for 2016, 2015 and 2014 were $125 million, $138 million, and $148 million, respectively. The Company’s cash payments per claim disposed (inclusive of legal costs) were approximately $71,000, $95,000, and $81,000 for the years ended December 31, 2016, 2015 and 2014, respectively. As discussed above, the Company’s objective is to achieve, where possible, resolution of asbestos claims pursuant to claims-handling agreements. Failure of claimants to meet certain medical and product exposure criteria in the Company’s administrative claims handling agreements has generally reduced the number of claims that would otherwise have been received by the Company in the tort system. In addition, certain court orders and legislative acts have reduced or eliminated the number of claims that the Company otherwise would have received by the Company in the tort system. These developments generally have had the effect of increasing the Company’s per-claim average indemnity payment over time. Beginning with the initial liability of $975 million established in 1993, the Company has accrued a total of approximately $4.9 billion through September 30, 2017, before insurance recoveries, for its asbestos-related liability. The Company’s estimates of its liability have been significantly affected by, among other factors, the volatility of asbestos-related litigation in the United States, the significant number of co-defendants that have filed for bankruptcy, the inherent uncertainty of future disease incidence and claiming patterns against the Company, the significant expansion of the defendants that are now sued in this litigation, and the continuing changes in the extent to which these defendants participate in the resolution of cases in which the Company is also a defendant. The Company continues to monitor trends that may affect its ultimate liability and analyze the developments and variables likely to affect the resolution of pending and future asbestos claims against the Company. The material components of the Company’s total accrued liability are determined by the Company in connection with its annual comprehensive legal review and consist of the following estimates, to the extent it is probable that such liabilities have been incurred and can be reasonably estimated: (i) the liability for asbestos claims already asserted against the Company; (ii) the liability for asbestos claims not yet asserted against the Company; and (iii) the legal defense costs estimated to be incurred in connection with the claims already asserted and those claims the Company believes will be asserted. As noted above, the Company conducts a comprehensive legal review of its asbestos-related liabilities and costs annually in connection with finalizing and reporting its annual results of operations, unless significant changes in trends or new developments warrant an earlier review. As part of its annual comprehensive legal review, the Company provides historical claims filing data to a third party with expertise in determining the impact of disease incidence and mortality on future filing trends to develop information to assist the Company in estimating the total number of future claims to be filed. The Company uses this estimate of total future claims, along with an estimation of disposition costs and related legal costs as inputs to develop its best estimate of total probable liability. If the results of the annual comprehensive legal review indicate that the existing amount of the accrued liability is lower (higher) than its reasonably estimable asbestos-related costs, then the Company will record an appropriate charge (credit) to the Company’s results of operations to increase (decrease) the accrued liability. The significant assumptions underlying the material components of the Company’s accrual are: a) settlements will continue to be limited almost exclusively to claimants who were exposed to the Company’s asbestos‑containing insulation prior to its exit from that business in 1958; b) claims will continue to be resolved primarily under the Company’s administrative claims agreements or on terms comparable to those set forth in those agreements; c) the incidence of serious asbestos‑related disease cases and claiming patterns against the Company for such cases do not change materially; d) the Company is substantially able to defend itself successfully at trial and on appeal; e) the number and timing of additional co‑defendant bankruptcies do not change significantly the assets available to participate in the resolution of cases in which the Company is a defendant; and f) co-defendants with substantial resources and assets continue to participate significantly in the resolution of future asbestos lawsuits and claims. For the years ended December 31, 2016 and 2015, the Company concluded that accruals in the amount of $692 million and $817 million, respectively, were required. These amounts have not been discounted for the time value of money. The Company’s comprehensive legal reviews resulted in charges of $0 million, $16 million and $46 million for the years ending December 31, 2016, 2015 and 2014, respectively. The Company believes it is reasonably possible that it will incur a loss for its asbestos-related liabilities in excess of the amount currently recognized, which is $692 million as of December 31, 2016. The Company estimates that reasonably possible losses could be as high as $825 million. This estimate of additional reasonably possible loss reflects a legal judgment about the number and cost of potential future claims and legal costs. The Company believes this estimate is consistent with the level of variability it has experienced when comparing actual results to recent near-term projections. However, it is also possible that the ultimate asbestos-related liability could be above this estimate. The Company expects a significant majority of the total number of claims to be received in the next ten years. This timeframe appropriately reflects the mortality of current and expected claimants in light of the Company’s sale of its insulation business unit in 1958. As noted above, the Company’s asbestos-related liability is based on a projection of new claims that will eventually be filed against the Company and the estimated average disposition cost of these claims and related legal costs. Changes in the significant assumptions noted above have the potential to impact these key factors, which are critical to the estimation of the Company’s asbestos-related liability significantly. Other Matters On July 5, 2016, the Company learned that the Enforcement Division of the Securities and Exchange Commission (“SEC”) is conducting an investigation into certain accounting and control matters pertaining to the Company’s determination of its asbestos-related liabilities. On May 13, 2016, the Company restated its consolidated financial statements for the years ended December 31, 2015, 2014 and 2013 in order to correct an error related to the Company’s method for estimating its future asbestos-related liabilities. The Company is cooperating with the SEC’s investigation. At this time, the Company is unable to predict the outcome of this matter or provide meaningful quantification of how the final resolution of this matter may impact its future consolidated financial statements, results of operations, or cash flows. Other litigation is pending against the Company, in many cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief. The Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based, including additional information, negotiations, settlements and other events.

Share Owners' Equity

Share Owners' Equity	9 Months Ended
	Sep. 30, 2017
Share Owners' Equity
Share Owners' Equity	10. Share Owners’ Equity The activity in share owners’ equity for the three months ended September 30, 2017 and 2016 is as follows: Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on July 1, 2017 $ 2 $ 3,088 $ (555) $ 92 $ (1,957) $ 109 $ 779 Reissuance of common stock (85,290 shares) 2 2 Stock compensation 5 5 Net earnings 126 7 133 Other comprehensive income 19 1 20 Balance on September 30, 2017 $ 2 $ 3,093 $ (553) $ 218 $ (1,938) $ 117 $ 939 Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on July 1, 2016 $ 2 $ 3,078 $ (566) $ (133) $ (2,033) $ 110 $ 458 Reissuance of common stock (114,039 shares) 3 3 Net earnings 108 6 114 Other comprehensive loss (57) (2) (59) Acquisitions of noncontrolling interests (1) (1) Balance on September 30, 2016 $ 2 $ 3,077 $ (563) $ (25) $ (2,090) $ 114 $ 515 The activity in share owners’ equity for the nine months ended September 30, 2017 and 2016 is as follows: Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on January 1, 2017 $ 2 $ 3,080 $ (560) (96) $ (2,172) $ 109 $ 363 Reissuance of common stock (286,455 shares) 7 7 Stock compensation 13 13 Net earnings 314 15 329 Other comprehensive income 234 (7) 227 Balance on September 30, 2017 $ 2 $ 3,093 $ (553) $ 218 $ (1,938) $ 117 $ 939 Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on January 1, 2016 $ 2 $ 3,064 $ (573) $ (305) $ (2,017) $ 108 $ 279 Issuance of common stock (505,471 shares) 5 5 Reissuance of common stock (297,875 shares) 10 10 Stock compensation 9 9 Net earnings 280 16 296 Other comprehensive loss (73) (10) (83) Acquisitions of noncontrolling interests (1) (1) Balance on September 30, 2016 $ 2 $ 3,077 $ (563) $ (25) $ (2,090) $ 114 $ 515 The Company has 250,000,000 shares of common stock authorized with a par value of $.01 per share. Shares outstanding are as follows: Shares Outstanding (in thousands) September 30, December 31, September 30, 2017 2016 2016 Shares of common stock issued (including treasury shares) 185,722 185,355 185,418 Treasury shares 22,731 23,017 23,221

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Sep. 30, 2017
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss	11. Accumulated Other Comprehensive Loss The activity in accumulated other comprehensive loss for the three months ended September 30, 2017 and 2016 is as follows: Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on July 1, 2017 $ (578) $ (14) $ (1,365) $ (1,957) Change before reclassifications 9 (2) 7 Amounts reclassified from accumulated other comprehensive income (a) 19 (b) 19 Translation effect (7) (7) Other comprehensive income attributable to the Company 9 — 10 19 Balance on September 30, 2017 $ (569) $ (14) $ (1,355) $ (1,938) Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on July 1, 2016 $ (574) $ (11) $ (1,448) $ (2,033) Change before reclassifications (77) (77) Amounts reclassified from accumulated other comprehensive income (1) (a) 26 (b) 25 Translation effect (5) (5) Other comprehensive income (loss) attributable to the Company (77) (1) 21 (57) Balance on September 30, 2016 $ (651) $ (12) $ (1,427) $ (2,090) (a) Amount is included in Cost of goods sold on the Condensed Consolidated Results of Operations (see Note 4 for additional information). (b) Amount is included in the computation of net periodic pension cost (see Note 6 for additional information) and net postretirement benefit cost. The activity in accumulated other comprehensive loss for the nine months ended September 30, 2017 and 2016 is as follows: Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on January 1, 2017 $ (788) $ (4) $ (1,380) $ (2,172) Change before reclassifications 219 (12) 207 Amounts reclassified from accumulated other comprehensive income (10) (a) 58 (b) 48 Translation effect (21) (21) Other comprehensive income (loss) attributable to the Company 219 (10) 25 234 Balance on September 30, 2017 $ (569) $ (14) $ (1,355) $ (1,938) Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on January 1, 2016 $ (568) $ (17) $ (1,432) $ (2,017) Change before reclassifications (83) (83) Amounts reclassified from accumulated other comprehensive income 4 (a) (2) (b) 2 Translation effect 6 6 Tax effect 1 1 2 Other comprehensive income (loss) attributable to the Company (83) 5 5 (73) Balance on September 30, 2016 $ (651) $ (12) $ (1,427) $ (2,090) (a) Amount is included in Cost of goods sold on the Condensed Consolidated Results of Operations (see Note 4 for additional information). (b) Amount is included in the computation of net periodic pension cost (see Note 6 for additional information) and net postretirement benefit cost.

Other Expense (Income), net

Other Expense (Income), net	9 Months Ended
	Sep. 30, 2017
Other Expense (Income), net
Other Expense (Income), net	12. Other Expense (Income), net Other expense (income), net for the three and nine months ended September 30, 2017 and 2016 included the following: Three months ended September 30, Nine months ended September 30, 2017 2016 2017 2016 Restructuring, asset impairment and other charges $ $ $ 49 $ 19 Gain on sale of land in China (7) Foreign currency exchange loss 3 2 3 6 Intangible amortization expense 11 10 31 30 Royalty income (4) (4) (11) (9) Other income (5) (13) (11) (15) $ 5 $ (5) $ 61 $ 24

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2017
Earnings Per Share
Earnings Per Share	13. Earnings Per Share The following tables set forth the computation of basic and diluted earnings per share: Three months ended September 30, 2017 2016 Numerator: Net earnings attributable to the Company $ 126 $ 108 Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding 162,866 162,080 Effect of dilutive securities: Stock options and other 2,127 1,124 Denominator for diluted earnings per share-adjusted weighted average shares outstanding 164,993 163,204 Basic earnings per share: Earnings from continuing operations $ 0.78 $ 0.68 Loss from discontinued operations (0.01) (0.02) Net earnings $ 0.77 $ 0.66 Diluted earnings per share: Earnings from continuing operations $ 0.77 $ 0.68 Loss from discontinued operations (0.01) (0.02) Net earnings $ 0.76 $ 0.66 Options to purchase 1,168,671 and 2,858,371 weighted average shares of common stock which were outstanding during the three months ended September 30, 2017 and 2016, respectively, were not included in the computation of diluted earnings per share because the options exercise price was greater than the average market price of the common shares. Nine months ended September 30, 2017 2016 Numerator: Net earnings attributable to the Company $ 314 $ 280 Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding 162,658 161,744 Effect of dilutive securities: Stock options and other 1,782 863 Denominator for diluted earnings per share-adjusted weighted average shares outstanding 164,440 162,607 Basic earnings per share: Earnings from continuing operations $ 1.94 $ 1.76 Loss from discontinued operations (0.01) (0.04) Net earnings $ 1.93 $ 1.72 Diluted earnings per share: Earnings from continuing operations $ 1.92 $ 1.75 Loss from discontinued operations (0.01) (0.04) Net earnings $ 1.91 $ 1.71 Options to purchase 1,664,845 and 2,922,833 weighted average shares of common stock which were outstanding during the nine months ended September 30, 2017 and 2016, respectively, were not included in the computation of diluted earnings per share because the options exercise price was greater than the average market price of the common shares.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	9 Months Ended
	Sep. 30, 2017
Supplemental Cash Flow Information
Supplemental Cash Flow Information	14. Supplemental Cash Flow Information Financial information regarding the Company’s supplemental cash flow information is as follows: Nine months ended September 30, 2017 2016 Interest paid in cash $ 209 $ 214 Income taxes paid in cash (all non-U.S.) 120 93 Cash interest for the nine months ended September 30, 2017 includes $16 million of note repurchase premiums related to debt that was repaid prior to its maturity. The Company uses various factoring programs to sell certain receivables to financial institutions as part of managing its cash flows. At September 30, 2017 and September 30, 2016, the amount of receivables sold by the Company was $145 million and $240 million, respectively. Any continuing involvement with the sold receivables is immaterial.

Discontinued Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2017
Discontinued Operations
Discontinued Operations	15. Discontinued Operations On April 4, 2016, the annulment committee formed by the World Bank’s International Centre for Settlement of Investment Disputes (“ICSID”) ruled that OI European Group B.V. (“OIEG”), a subsidiary of the Company, is free to pursue the enforcement of a prior arbitration award (the “Award”) against Venezuela. As of September 30, 2017, that Award amounts to more than $500 million, including reimbursement of expenses and accrued interest. Venezuela’s application to annul the Award was heard by an ad hoc committee of the ICSID in September 2017, but no decision has been rendered yet. On July 31, 2017, OIEG sold its right, title and interest in amounts due under the Award to an Ireland-domiciled investment fund. Under the terms of the sale, OIEG received a payment, in cash, at closing equal to $115 million (the “Cash Payment”). OIEG may also receive additional payments in the future (“Deferred Amounts”) calculated based on the total compensation that is received from Venezuela as a result of collection efforts or as settlement of the Award with Venezuela. In the event that the Award is partially or completely annulled by the ICSID ad hoc annulment committee, OIEG may be required to repay to the purchaser up to the entire amount of the Cash Payment based on a formula tied to the amount of the Award (if any) that is annulled. In addition, OIEG’s right to receive any Deferred Amounts is subject to the limitations described below. OIEG’s interest in any amounts received in the future from Venezuela in respect of the Award is limited to a percentage of such recovery after taking into account reimbursement of the Cash Payment to the purchaser and reimbursement of legal fees and expenses incurred by the Company and the purchaser. OIEG’s percentage of such recovery will also be reduced over time. Because the Award has yet to be satisfied, the annulment proceeding is pending, and the ability to successfully enforce the Award in countries that are party to the ICSID Convention is subject to significant challenges, the Company is unable to reasonably predict the amount of recoveries from the Award, if any, to which the Company may be entitled in the future. Any future amounts that the Company may receive from the Award are highly speculative and the timing of any such future payments, if any, is highly uncertain. As such, there can be no assurance that the Company will receive any future payments under the Award beyond the Cash Payment. Except as noted above in connection with the annulment proceeding that is pending before the ICSID ad hoc committee, the Cash Payment is not subject to any forfeiture or future adjustment. A separate arbitration involving other subsidiaries of the Company is pending before ICSID to obtain compensation primarily for third-party minority shareholders’ lost interests in the two expropriated plants. As of September 30, 2017, the Company deferred the gain contingency on the sale of its rights in amounts due under the Award pending the ad hoc committee of the ICSID rendering its decision regarding Venezuela’s application to annul the Award. The loss from discontinued operations of $2 million and $6 million for the nine months ended September 30, 2017 and September 30, 2016, respectively, relates to ongoing costs for the Venezuelan expropriation.

New Accounting Pronouncement

New Accounting Pronouncement	9 Months Ended
	Sep. 30, 2017
New Accounting Pronouncement
New Accounting Pronouncement	16. New Accounting Pronouncement Revenue from Contracts with Customers - In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers," which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. In August 2015, the FASB issued ASU No. 2015-14, “Revenue from Contracts with Customers”, which delayed by one year the effective date of the new revenue recognition standard, which will be effective for the Company on January 1, 2018. The Company has started an implementation process, including a review of customer contracts, to evaluate the effect this standard will have on its consolidated financial statements and related disclosures. At this time, the Company does not expect that the implementation of this standard in 2018 will have a significant impact on the timing in which it recognizes revenue. While the Company continues to assess the potential impacts of the new standard, the Company does not currently expect the adoption of the new standard to have a material impact on consolidated net income or the consolidated balance sheet. The standard requires new substantial disclosures and the Company continues to evaluate these requirements. The Company plans to select the modified retrospective transition method upon adoption effective January 1, 2018. Leases - In February 2016, the FASB issued ASU No. 2016-02, “Leases”. Under this guidance, lessees will be required to recognize on the balance sheet a lease liability and a right-of-use asset for all leases, with the exception of short-term leases. The lease liability represents the lessee's obligation to make lease payments arising from a lease, and will be measured as the present value of the lease payments. The right-of-use asset represents the lessee’s right to use a specified asset for the lease term, and will be measured at the lease liability amount, adjusted for lease prepayment, lease incentives received and the lessee’s initial direct costs. The standard also requires a lessee to recognize a single lease cost allocated over the lease term, generally on a straight-line basis. The new guidance is effective for the Company on January 1, 2019. ASU No. 2016-02 is required to be applied using the modified retrospective approach for all leases existing as of the effective date and provides for certain practical expedients. Early adoption is permitted. The Company is currently evaluating the effects that the adoption of ASU No. 2016-02 will have on the Company’s consolidated financial statements, and anticipates the new guidance will significantly impact its consolidated financial statements as the Company has a significant number of leases. As further described in Note 16 in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, the Company had minimum lease commitments under non-cancellable operating leases totaling $205 million as of December 31, 2016. Compensation – Retirement Benefits - In March 2017, the FASB issued ASU No. 2017-07, “Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost” which requires the service cost component to be presented with other employee compensation costs in operating income within the income statement while the other components will be reported separately outside of operations. Application of the standard is required for annual periods beginning after December 15, 2017. The adoption of this standard is not expected to have a material impact on the Company’s condensed consolidated financial statements. Derivatives and Hedging – In August 2017, the FASB issued ASU No. 2017-12, “Targeted Improvements to Accounting for Hedging Activities” which improves the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. Application of the standard is required for annual periods beginning after December 15, 2018. The adoption of this standard is not expected to have a material impact on the Company’s condensed consolidated financial statements.

Financial Information for Subsi

Financial Information for Subsidiary Guarantors and Non-Guarantors	9 Months Ended
	Sep. 30, 2017
Financial Information for Subsidiary Guarantors and Non-Guarantors
Financial Information for Subsidiary Guarantors and Non-Guarantors	17. Financial Information for Subsidiary Guarantors and Non-Guarantors The following presents condensed consolidating financial information for the Company, segregating: (1) Owens-Illinois, Inc., the issuer of senior debentures (the “Parent”); (2) the two subsidiaries which have guaranteed the senior debentures on a subordinated basis (the “Guarantor Subsidiaries”); and (3) all other subsidiaries (the “Non-Guarantor Subsidiaries”). The Guarantor Subsidiaries are 100% owned direct and indirect subsidiaries of the Company and their guarantees are full, unconditional and joint and several. They have no operations and function only as intermediate holding companies. Certain reclassifications have been made to conform all of the financial information to the financial presentation on a consolidated basis. The principal eliminations relate to investments in subsidiaries and intercompany balances and transactions. September 30, 2017 Guarantor Non-Guarantor Balance Sheet Parent Subsidiaries Subsidiaries Eliminations Consolidated Current assets: Cash and cash equivalents $ — $ — $ 339 $ — $ 339 Trade receivables, net 1,028 1,028 Inventories 1,046 1,046 Prepaid expenses and other current assets 254 254 Total current assets — — 2,667 — 2,667 Investments in and advances to subsidiaries 1,488 1,465 (2,953) — Property, plant and equipment, net 3,036 3,036 Goodwill 2,621 2,621 Intangibles, net 473 473 Other assets 1,202 1,202 Total assets $ 1,488 $ 1,465 $ 9,999 $ (2,953) $ 9,999 Current liabilities : Short-term loans and long-term debt due within one year $ 22 $ — $ 243 $ (22) $ 243 Current portion of asbestos liability 115 115 Accounts payable 1,087 1,087 Other liabilities 1 617 (1) 617 Other liabilities - discontinued operations 115 115 Total current liabilities 138 — 2,062 (23) 2,177 Long-term debt 5,378 5,378 Asbestos-related liabilities 528 528 Other long-term liabilities 977 977 Share owners’ equity 822 1,465 1,465 (2,930) 822 Noncontrolling interests 117 117 Total liabilities and share owners’ equity $ 1,488 $ 1,465 $ 9,999 $ (2,953) $ 9,999 December 31, 2016 Non- Guarantor Guarantor Balance Sheet Parent Subsidiaries Subsidiaries Eliminations Consolidated Current assets: Cash and cash equivalents $ — $ — $ 492 $ — $ 492 Trade receivables, net 580 580 Inventories 983 983 Prepaid expenses and other current assets 199 199 Total current assets — — 2,254 — 2,254 Investments in and advances to subsidiaries 1,198 946 (2,144) — Property, plant and equipment, net 2,880 2,880 Goodwill 2,462 2,462 Intangibles, net 464 464 Other assets 1,075 1,075 Total assets $ 1,198 $ 946 $ 9,135 $ (2,144) $ 9,135 Current liabilities : Short-term loans and long-term debt due within one year $ — $ — $ 195 $ — $ 195 Current portion of asbestos liability 115 115 Accounts payable 1,135 1,135 Other liabilities 2 615 (2) 615 Total current liabilities 117 — 1,945 (2) 2,060 Long-term debt 250 5,133 (250) 5,133 Asbestos-related liabilities 577 577 Other long-term liabilities 1,002 1,002 Share owners’ equity 254 946 946 (1,892) 254 Noncontrolling interests 109 109 Total liabilities and share owners’ equity $ 1,198 $ 946 $ 9,135 $ (2,144) $ 9,135 September 30, 2016 Non- Guarantor Guarantor Balance Sheet Parent Subsidiaries Subsidiaries Eliminations Consolidated Current assets: Cash and cash equivalents $ — $ — $ 294 $ — $ 294 Trade receivables, net 857 857 Inventories 1,057 1,057 Prepaid expenses and other current assets 234 234 Total current assets — — 2,442 — 2,442 Investments in and advances to subsidiaries 1,431 1,174 (2,605) — Property, plant and equipment, net 2,917 2,917 Goodwill 2,534 2,534 Intangibles, net 490 490 Other assets 1,114 1,114 Total assets $ 1,431 $ 1,174 $ 9,497 $ (2,605) $ 9,497 Current liabilities : Short-term loans and long-term debt due within one year $ — $ — $ 262 $ — $ 262 Current portion of asbestos liability 130 130 Accounts payable 1,059 1,059 Other liabilities 7 582 (7) 582 Total current liabilities 137 — 1,903 (7) 2,033 Long-term debt 250 5,333 (250) 5,333 Asbestos-related liabilities 643 643 Other long-term liabilities 973 973 Share owners’ equity 401 1,174 1,174 (2,348) 401 Noncontrolling interests 114 114 Total liabilities and share owners’ equity $ 1,431 $ 1,174 $ 9,497 $ (2,605) $ 9,497 Three months ended September 30, 2017 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ 1,791 $ — $ 1,791 Cost of goods sold (1,438) (1,438) Gross profit — — 353 — 353 Selling and administrative expense (120) (120) Research, development and engineering expense (15) (15) Net intercompany interest — Interest expense, net (63) (63) Equity earnings from subsidiaries 126 126 (252) — Other equity earnings 22 22 Other expense, net (5) (5) Earnings before income taxes 126 126 172 (252) 172 Provision for income taxes (37) (37) Earnings from continuing operations 126 126 135 (252) 135 Loss from discontinued operations (2) (2) Net earnings 126 126 133 (252) 133 Net (earnings) attributable to noncontrolling interests (7) (7) Net earnings attributable to the Company $ 126 $ 126 $ 126 $ (252) $ 126 Three months ended September 30, 2017 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ 126 $ 126 $ 133 $ (252) $ 133 Other comprehensive income, net 12 12 20 (24) 20 Total comprehensive income 138 138 153 (276) 153 Comprehensive income attributable to noncontrolling interests (8) (8) Comprehensive income attributable to the Company $ 138 $ 138 $ 145 $ (276) $ 145 Three months ended September 30, 2016 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ 1,712 $ — $ 1,712 Cost of goods sold (1,376) (1,376) Gross profit — — 336 — 336 Selling and administrative expense (121) (121) Research, development and engineering expense (16) (16) Net intercompany interest 5 (5) — Interest expense, net (5) (61) (66) Equity earnings from subsidiaries 108 108 (216) — Other equity earnings 15 15 Other expense, net 5 5 Earnings before income taxes 108 108 153 (216) 153 Provision for income taxes (36) (36) Earnings from continuing operations 108 108 117 (216) 117 Loss from discontinued operations (3) (3) Net earnings 108 108 114 (216) 114 Net (earnings) attributable to noncontrolling interests (6) (6) Net earnings attributable to the Company $ 108 $ 108 $ 108 $ (216) $ 108 Three months ended September 30, 2016 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ 108 $ 108 $ 114 $ (216) $ 114 Other comprehensive loss, net (63) (63) (59) 126 (59) Total comprehensive income 45 45 55 (90) 55 Comprehensive income attributable to noncontrolling interests (4) (4) Comprehensive income attributable to the Company $ 45 $ 45 $ 51 $ (90) $ 51 Nine months ended September 30, 2017 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ 5,157 $ — $ 5,157 Cost of goods sold (4,143) (4,143) Gross profit — — 1,014 — 1,014 Selling and administrative expense (362) (362) Research, development and engineering expense (46) (46) Net intercompany interest 21 (21) — Interest expense, net (21) (183) (204) Equity earnings from subsidiaries 314 314 (628) — Other equity earnings 55 55 Other expense, net (61) (61) Earnings before income taxes 314 314 396 (628) 396 Provision for income taxes (65) (65) Earnings from continuing operations 314 314 331 (628) 331 Loss from discontinued operations (2) (2) Net earnings 314 314 329 (628) 329 Net (earnings) attributable to noncontrolling interests (15) (15) Net earnings attributable to the Company $ 314 $ 314 $ 314 $ (628) $ 314 Nine months ended September 30, 2017 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ 314 $ 314 $ 329 $ (628) $ 329 Other comprehensive income, net 219 219 227 (438) 227 Total comprehensive income 533 533 556 (1,066) 556 Comprehensive income attributable to noncontrolling interests (8) (8) Comprehensive income attributable to the Company $ 533 $ 533 $ 548 $ (1,066) $ 548 Nine months ended September 30, 2016 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ 5,060 $ — $ 5,060 Cost of goods sold (4,063) (4,063) Gross profit — — 997 — 997 Selling and administrative expense (375) (375) Research, development and engineering expense (48) (48) Net intercompany interest 15 (15) — Interest expense, net (15) (184) (199) Equity earnings from subsidiaries 280 280 (560) — Other equity earnings 44 44 Other expense, net (24) (24) Earnings before income taxes 280 280 395 (560) 395 Provision for income taxes (93) (93) Earnings from continuing operations 280 280 302 (560) 302 Loss from discontinued operations (6) (6) Net earnings 280 280 296 (560) 296 Net (earnings) attributable to noncontrolling interests (16) (16) Net earnings attributable to the Company $ 280 $ 280 $ 280 $ (560) $ 280 Nine months ended September 30, 2016 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ 280 $ 280 $ 296 $ (560) $ 296 Other comprehensive loss, net (89) (89) (83) 178 (83) Total comprehensive income 191 191 213 (382) 213 Comprehensive income attributable to noncontrolling interests (6) (6) Comprehensive income attributable to the Company $ 191 $ 191 $ 207 $ (382) $ 207 Nine months ended September 30, 2017 Non- Guarantor Guarantor Cash Flows Parent Subsidiaries Subsidiaries Eliminations Consolidated Cash provided by (utilized in) operating activities $ (50) $ — 87 $ — $ 37 Cash utilized in investing activities (200) (200) Cash provided by (utilized in) financing activities 50 (64) (14) Effect of exchange rate change on cash 24 24 Net change in cash — — (153) — (153) Cash at beginning of period 492 492 Cash at end of period $ — $ — $ 339 $ — $ 339 Nine months ended September 30, 2016 Non- Guarantor Guarantor Cash Flows Parent Subsidiaries Subsidiaries Eliminations Consolidated Cash utilized in operating activities $ (45) $ — $ 265 $ — $ 220 Cash utilized in investing activities (282) (282) Cash provided by financing activities 45 (84) (39) Effect of exchange rate change on cash (4) (4) Net change in cash — — (105) — (105) Cash at beginning of period 399 399 Cash at end of period $ — $ — $ 294 $ — $ 294

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2017
Segment Information
Net sales for the Company's reportable segments	Three months ended September 30, Nine months ended September 30, 2017 2016 2017 2016 Net sales: Europe $ 624 $ 586 $ 1,813 $ 1,795 North America 551 578 1,651 1,709 Latin America 412 365 1,123 1,022 Asia Pacific 188 170 516 487 Reportable segment totals 1,775 1,699 5,103 5,013 Other 16 13 54 47 Net sales $ 1,791 $ 1,712 $ 5,157 $ 5,060
Segment operating profit (loss) for the Company's reportable segments	Three months ended September 30, Nine months ended September 30, 2017 2016 2017 2016 Segment operating profit: Europe $ 81 $ 64 $ 220 $ 192 North America 75 79 252 247 Latin America 84 74 207 194 Asia Pacific 20 20 51 48 Reportable segment totals 260 237 730 681 Items excluded from segment operating profit: Retained corporate costs and other (25) (18) (81) (75) Restructuring, asset impairment and other (49) (12) Interest expense, net (63) (66) (204) (199) Earnings from continuing operations before income taxes $ 172 $ 153 $ 396 $ 395
Total assets for the Company's reportable segments	September 30, December 31, September 30, 2017 2016 2016 Total assets: Europe $ 3,140 $ 2,792 $ 2,972 North America 2,826 2,522 2,536 Latin America 2,772 2,537 2,629 Asia Pacific 1,046 926 1,025 Reportable segment totals 9,784 8,777 9,162 Other 215 358 335 Consolidated totals $ 9,999 $ 9,135 $ 9,497

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2017
Inventories
Major classes of inventory	September 30, December 31, September 30, 2017 2016 2016 Finished goods $ 875 $ 827 $ 892 Raw materials 129 118 127 Operating supplies 42 38 38 $ 1,046 $ 983 $ 1,057

Prepaid Expenses and Other Cu26

Prepaid Expenses and Other Current Assets (Tables)	9 Months Ended
	Sep. 30, 2017
Prepaid Expenses and Other Current Assets
Schedule of Prepaid expenses and other current assets	September 30, December 31, September 30, 2017 2016 2016 Prepaid expenses $ 50 $ 50 $ 61 Value added taxes 44 46 42 Other 160 103 131 $ 254 $ 199 $ 234

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
	Sep. 30, 2017
Derivative Instruments
Effect of commodity forward contracts designated as cash flow hedges on the results of operations	The effect of the commodity forward contracts on the results of operations for the three months ended September 30, 2017 and 2016 is as follows: Amount of Gain (Loss) Reclassified from Amount of (Loss) Recognized in OCI on Accumulated OCI into Income Commodity Forward Contracts (reported in cost of goods sold) (Effective Portion) (Effective Portion) 2017 2016 2017 2016 $ (1) $ (1) $ — $ — The effect of the commodity forward contracts on the results of operations for the nine months ended September 30, 2017 and 2016 is as follows: Amount of Gain (Loss) Reclassified from Amount of Gain Recognized in OCI on Accumulated OCI into Income Commodity Forward Contracts (reported in cost of goods sold) (Effective Portion) (Effective Portion) 2017 2016 2017 2016 $ 3 $ 2 $ — $ —
Effect of the foreign exchange contracts not designated as hedging instruments on the results of operations	The effect of the foreign exchange derivative contracts on the results of operations for the three months ended September 30, 2017 and 2016 is as follows: Amount of Gain (Loss) Location of Gain (Loss) Recognized in Income on Recognized in Income on Foreign Exchange Contracts Foreign Exchange Contracts 2017 2016 Other expense $ (2) $ 4 The effect of the foreign exchange derivative contracts on the results of operations for the nine months ended September 30, 2017 and 2016 is as follows: Amount of Gain Location of Gain Recognized in Income on Recognized in Income on Foreign Exchange Contracts Foreign Exchange Contracts 2017 2016 Other expense $ 4 $ 6
Schedule of selected information relating to fair value swaps	Amount Hedged Receive Rate Average Spread Senior Notes due 2024 € 400 3.125 % 2.5 %
Balance Sheet Classification of derivative instruments	Fair Value Balance Sheet September 30, December 31, September 30, Location 2017 2016 2016 Asset derivatives: Derivatives designated as hedging instruments: Commodity futures contracts b $ 1 $ 6 $ 2 Interest rate swaps designated as fair value hedges a 2 Derivatives not designated as hedging instruments: Foreign exchange derivative contracts a 2 9 8 Total asset derivatives $ 5 $ 15 $ 10 Liability derivatives: Derivatives designated as hedging instruments: Commodity futures contracts c $ 1 $ — $ — Interest rate swaps designated as fair value hedges d 5 Derivatives not designated as hedging instruments: Foreign exchange derivative contracts c 3 5 2 Total liability derivatives $ 9 $ 5 $ 2

Restructuring Accruals (Tables)

Restructuring Accruals (Tables)	9 Months Ended
	Sep. 30, 2017
Restructuring Accruals
Selected information related to the restructuring accruals	Selected information related to the restructuring accruals for the three months ended September 30, 2017 and 2016 is as follows: Other Restructuring Actions Balance at July 1, 2017 $ 111 Net cash paid, principally severance and related benefits (14) Other, including foreign exchange translation 1 Balance at September 30, 2017 $ Other Asia Pacific Restructuring Total Restructuring Actions Restructuring Balance at July 1, 2016 $ 6 $ 28 $ 34 Net cash paid, principally severance and related benefits (1) (2) Other, including foreign exchange translation (2) Balance at September 30, 2016 $ 5 $ 24 $ 29 Selected information related to the restructuring accruals for the nine months ended September 30, 2017 and 2016 is as follows: Other Restructuring Actions Balance at January 1, 2017 $ 85 Charges Write-down of assets to net realizable value Net cash paid, principally severance and related benefits Other, including foreign exchange translation Balance at September 30, 2017 $ Other Asia Pacific Restructuring Total Restructuring Actions Restructuring Balance at January 1, 2016 $ 7 $ 36 $ 43 Charges 19 Write-down of assets to net realizable value (7) Net cash paid, principally severance and related benefits (20) Other, including foreign exchange translation (6) Balance at September 30, 2016 $ 5 $ 24 $ 29

Pension Benefit Plans (Tables)

Pension Benefit Plans (Tables)	9 Months Ended
	Sep. 30, 2017
Pension Benefit Plans.
Components of net periodic pension cost (income) and net periodic postretirement (benefit) cost	The components of the net periodic pension cost for the three months ended September 30, 2017 and 2016 are as follows: U.S. Non-U.S. 2017 2016 2017 2016 Service cost $ 4 $ 3 $ 4 $ 4 Interest cost 20 23 11 12 Expected asset return (33) (37) (18) (19) Amortization: Actuarial loss 14 16 5 5 Net periodic pension cost $ 5 $ 5 $ 2 $ 2 The components of the net periodic pension cost for the nine months ended September 30, 2017 and 2016 are as follows: U.S. Non-U.S. 2017 2016 2017 2016 Service cost $ 11 $ 11 $ 12 $ 13 Interest cost 59 72 33 38 Expected asset return (98) (113) (54) (61) Amortization: Actuarial loss 44 47 15 15 Net periodic pension cost $ 16 $ 17 $ 6 $ 5

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2017
Debt
Long-term Debt	September 30, December 31, September 30, 2017 2016 2016 Secured Credit Agreement: Revolving Credit Facility: Revolving Loans $ 200 $ — $ — Term Loans: Term Loan A 1,202 1,395 1,516 Term Loan A (€279 million) 308 282 303 Term Loan B 558 Senior Notes: 6.75%, due 2020 (€500 million) 586 523 557 4.875%, due 2021 (€330 million) 386 345 367 5.00%, due 2022 496 495 495 5.875%, due 2023 684 682 681 3.125%, due 2024 (€725 million at September 30, 2017 and €500 million at December 31, 2016) 840 520 6.375%, due 2025 295 294 294 5.375%, due 2025 297 297 296 Senior Debentures: 7.80%, due 2018 22 250 250 Capital Leases 54 57 62 Other 56 26 30 Total long-term debt 5,426 5,166 5,409 Less amounts due within one year 48 33 76 Long-term debt $ 5,378 $ 5,133 $ 5,333
Information related to accounts receivable securitization program	September 30, December 31, September 30, 2017 2016 2016 Balance (included in short-term loans) $ 170 $ 152 $ 158 Weighted average interest rate 0.65 % 0.74 % 0.67 %
Fair values of the Company's significant fixed rate debt obligations	Fair values at September 30, 2017 of the Company’s significant fixed rate debt obligations are as follows: Principal Indicated Amount Market Price Fair Value Senior Notes: 6.75%, due 2020 (€500 million) $ 589 $ 118.38 $ 697 4.875%, due 2021 (€330 million) 389 113.85 443 5.00%, due 2022 500 105.80 529 5.875%, due 2023 700 110.65 775 3.125%, due 2024 (€725 million) 854 103.38 883 6.375%, due 2025 300 113.10 339 5.375%, due 2025 300 106.98 321 Senior Debentures: 7.80%, due 2018 22 103.77 23

Share Owners' Equity (Tables)

Share Owners' Equity (Tables)	9 Months Ended
	Sep. 30, 2017
Share Owners' Equity
Activity in share owner's equity	The activity in share owners’ equity for the three months ended September 30, 2017 and 2016 is as follows: Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on July 1, 2017 $ 2 $ 3,088 $ (555) $ 92 $ (1,957) $ 109 $ 779 Reissuance of common stock (85,290 shares) 2 2 Stock compensation 5 5 Net earnings 126 7 133 Other comprehensive income 19 1 20 Balance on September 30, 2017 $ 2 $ 3,093 $ (553) $ 218 $ (1,938) $ 117 $ 939 Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on July 1, 2016 $ 2 $ 3,078 $ (566) $ (133) $ (2,033) $ 110 $ 458 Reissuance of common stock (114,039 shares) 3 3 Net earnings 108 6 114 Other comprehensive loss (57) (2) (59) Acquisitions of noncontrolling interests (1) (1) Balance on September 30, 2016 $ 2 $ 3,077 $ (563) $ (25) $ (2,090) $ 114 $ 515 The activity in share owners’ equity for the nine months ended September 30, 2017 and 2016 is as follows: Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on January 1, 2017 $ 2 $ 3,080 $ (560) (96) $ (2,172) $ 109 $ 363 Reissuance of common stock (286,455 shares) 7 7 Stock compensation 13 13 Net earnings 314 15 329 Other comprehensive income 234 (7) 227 Balance on September 30, 2017 $ 2 $ 3,093 $ (553) $ 218 $ (1,938) $ 117 $ 939 Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on January 1, 2016 $ 2 $ 3,064 $ (573) $ (305) $ (2,017) $ 108 $ 279 Issuance of common stock (505,471 shares) 5 5 Reissuance of common stock (297,875 shares) 10 10 Stock compensation 9 9 Net earnings 280 16 296 Other comprehensive loss (73) (10) (83) Acquisitions of noncontrolling interests (1) (1) Balance on September 30, 2016 $ 2 $ 3,077 $ (563) $ (25) $ (2,090) $ 114 $ 515
Schedule of shares outstanding	Shares Outstanding (in thousands) September 30, December 31, September 30, 2017 2016 2016 Shares of common stock issued (including treasury shares) 185,722 185,355 185,418 Treasury shares 22,731 23,017 23,221

Accumulated Other Comprehensi32

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Sep. 30, 2017
Accumulated Other Comprehensive Loss
Component of accumulated other comprehensive loss	The activity in accumulated other comprehensive loss for the three months ended September 30, 2017 and 2016 is as follows: Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on July 1, 2017 $ (578) $ (14) $ (1,365) $ (1,957) Change before reclassifications 9 (2) 7 Amounts reclassified from accumulated other comprehensive income (a) 19 (b) 19 Translation effect (7) (7) Other comprehensive income attributable to the Company 9 — 10 19 Balance on September 30, 2017 $ (569) $ (14) $ (1,355) $ (1,938) Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on July 1, 2016 $ (574) $ (11) $ (1,448) $ (2,033) Change before reclassifications (77) (77) Amounts reclassified from accumulated other comprehensive income (1) (a) 26 (b) 25 Translation effect (5) (5) Other comprehensive income (loss) attributable to the Company (77) (1) 21 (57) Balance on September 30, 2016 $ (651) $ (12) $ (1,427) $ (2,090) (a) Amount is included in Cost of goods sold on the Condensed Consolidated Results of Operations (see Note 4 for additional information). (b) Amount is included in the computation of net periodic pension cost (see Note 6 for additional information) and net postretirement benefit cost. The activity in accumulated other comprehensive loss for the nine months ended September 30, 2017 and 2016 is as follows: Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on January 1, 2017 $ (788) $ (4) $ (1,380) $ (2,172) Change before reclassifications 219 (12) 207 Amounts reclassified from accumulated other comprehensive income (10) (a) 58 (b) 48 Translation effect (21) (21) Other comprehensive income (loss) attributable to the Company 219 (10) 25 234 Balance on September 30, 2017 $ (569) $ (14) $ (1,355) $ (1,938) Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on January 1, 2016 $ (568) $ (17) $ (1,432) $ (2,017) Change before reclassifications (83) (83) Amounts reclassified from accumulated other comprehensive income 4 (a) (2) (b) 2 Translation effect 6 6 Tax effect 1 1 2 Other comprehensive income (loss) attributable to the Company (83) 5 5 (73) Balance on September 30, 2016 $ (651) $ (12) $ (1,427) $ (2,090) (a) Amount is included in Cost of goods sold on the Condensed Consolidated Results of Operations (see Note 4 for additional information). (b) Amount is included in the computation of net periodic pension cost (see Note 6 for additional information) and net postretirement benefit cost.

Other Expense (Income), net (Ta

Other Expense (Income), net (Tables)	9 Months Ended
	Sep. 30, 2017
Other Expense (Income), net
Schedule of other expense (income), net	Three months ended September 30, Nine months ended September 30, 2017 2016 2017 2016 Restructuring, asset impairment and other charges $ $ $ 49 $ 19 Gain on sale of land in China (7) Foreign currency exchange loss 3 2 3 6 Intangible amortization expense 11 10 31 30 Royalty income (4) (4) (11) (9) Other income (5) (13) (11) (15) $ 5 $ (5) $ 61 $ 24

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2017
Earnings Per Share
Computation of basic and diluted earnings per share	2017 2016 Numerator: Net earnings attributable to the Company $ 126 $ 108 Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding 162,866 162,080 Effect of dilutive securities: Stock options and other 2,127 1,124 Denominator for diluted earnings per share-adjusted weighted average shares outstanding 164,993 163,204 Basic earnings per share: Earnings from continuing operations $ 0.78 $ 0.68 Loss from discontinued operations (0.01) (0.02) Net earnings $ 0.77 $ 0.66 Diluted earnings per share: Earnings from continuing operations $ 0.77 $ 0.68 Loss from discontinued operations (0.01) (0.02) Net earnings $ 0.76 $ 0.66 Nine months ended September 30, 2017 2016 Numerator: Net earnings attributable to the Company $ 314 $ 280 Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding 162,658 161,744 Effect of dilutive securities: Stock options and other 1,782 863 Denominator for diluted earnings per share-adjusted weighted average shares outstanding 164,440 162,607 Basic earnings per share: Earnings from continuing operations $ 1.94 $ 1.76 Loss from discontinued operations (0.01) (0.04) Net earnings $ 1.93 $ 1.72 Diluted earnings per share: Earnings from continuing operations $ 1.92 $ 1.75 Loss from discontinued operations (0.01) (0.04) Net earnings $ 1.91 $ 1.71

Supplemental Cash Flow Inform35

Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2017
Supplemental Cash Flow Information
Supplemental cash flow information	Nine months ended September 30, 2017 2016 Interest paid in cash $ 209 $ 214 Income taxes paid in cash (all non-U.S.) 120 93

Financial Information for Sub36

Financial Information for Subsidiary Guarantors and Non-Guarantors (Tables)	9 Months Ended
	Sep. 30, 2017
Financial Information for Subsidiary Guarantors and Non-Guarantors
Balance Sheet	September 30, 2017 Guarantor Non-Guarantor Balance Sheet Parent Subsidiaries Subsidiaries Eliminations Consolidated Current assets: Cash and cash equivalents $ — $ — $ 339 $ — $ 339 Trade receivables, net 1,028 1,028 Inventories 1,046 1,046 Prepaid expenses and other current assets 254 254 Total current assets — — 2,667 — 2,667 Investments in and advances to subsidiaries 1,488 1,465 (2,953) — Property, plant and equipment, net 3,036 3,036 Goodwill 2,621 2,621 Intangibles, net 473 473 Other assets 1,202 1,202 Total assets $ 1,488 $ 1,465 $ 9,999 $ (2,953) $ 9,999 Current liabilities : Short-term loans and long-term debt due within one year $ 22 $ — $ 243 $ (22) $ 243 Current portion of asbestos liability 115 115 Accounts payable 1,087 1,087 Other liabilities 1 617 (1) 617 Other liabilities - discontinued operations 115 115 Total current liabilities 138 — 2,062 (23) 2,177 Long-term debt 5,378 5,378 Asbestos-related liabilities 528 528 Other long-term liabilities 977 977 Share owners’ equity 822 1,465 1,465 (2,930) 822 Noncontrolling interests 117 117 Total liabilities and share owners’ equity $ 1,488 $ 1,465 $ 9,999 $ (2,953) $ 9,999 December 31, 2016 Non- Guarantor Guarantor Balance Sheet Parent Subsidiaries Subsidiaries Eliminations Consolidated Current assets: Cash and cash equivalents $ — $ — $ 492 $ — $ 492 Trade receivables, net 580 580 Inventories 983 983 Prepaid expenses and other current assets 199 199 Total current assets — — 2,254 — 2,254 Investments in and advances to subsidiaries 1,198 946 (2,144) — Property, plant and equipment, net 2,880 2,880 Goodwill 2,462 2,462 Intangibles, net 464 464 Other assets 1,075 1,075 Total assets $ 1,198 $ 946 $ 9,135 $ (2,144) $ 9,135 Current liabilities : Short-term loans and long-term debt due within one year $ — $ — $ 195 $ — $ 195 Current portion of asbestos liability 115 115 Accounts payable 1,135 1,135 Other liabilities 2 615 (2) 615 Total current liabilities 117 — 1,945 (2) 2,060 Long-term debt 250 5,133 (250) 5,133 Asbestos-related liabilities 577 577 Other long-term liabilities 1,002 1,002 Share owners’ equity 254 946 946 (1,892) 254 Noncontrolling interests 109 109 Total liabilities and share owners’ equity $ 1,198 $ 946 $ 9,135 $ (2,144) $ 9,135 September 30, 2016 Non- Guarantor Guarantor Balance Sheet Parent Subsidiaries Subsidiaries Eliminations Consolidated Current assets: Cash and cash equivalents $ — $ — $ 294 $ — $ 294 Trade receivables, net 857 857 Inventories 1,057 1,057 Prepaid expenses and other current assets 234 234 Total current assets — — 2,442 — 2,442 Investments in and advances to subsidiaries 1,431 1,174 (2,605) — Property, plant and equipment, net 2,917 2,917 Goodwill 2,534 2,534 Intangibles, net 490 490 Other assets 1,114 1,114 Total assets $ 1,431 $ 1,174 $ 9,497 $ (2,605) $ 9,497 Current liabilities : Short-term loans and long-term debt due within one year $ — $ — $ 262 $ — $ 262 Current portion of asbestos liability 130 130 Accounts payable 1,059 1,059 Other liabilities 7 582 (7) 582 Total current liabilities 137 — 1,903 (7) 2,033 Long-term debt 250 5,333 (250) 5,333 Asbestos-related liabilities 643 643 Other long-term liabilities 973 973 Share owners’ equity 401 1,174 1,174 (2,348) 401 Noncontrolling interests 114 114 Total liabilities and share owners’ equity $ 1,431 $ 1,174 $ 9,497 $ (2,605) $ 9,497
Results of Operations and Comprehensive Income	Three months ended September 30, 2017 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ 1,791 $ — $ 1,791 Cost of goods sold (1,438) (1,438) Gross profit — — 353 — 353 Selling and administrative expense (120) (120) Research, development and engineering expense (15) (15) Net intercompany interest — Interest expense, net (63) (63) Equity earnings from subsidiaries 126 126 (252) — Other equity earnings 22 22 Other expense, net (5) (5) Earnings before income taxes 126 126 172 (252) 172 Provision for income taxes (37) (37) Earnings from continuing operations 126 126 135 (252) 135 Loss from discontinued operations (2) (2) Net earnings 126 126 133 (252) 133 Net (earnings) attributable to noncontrolling interests (7) (7) Net earnings attributable to the Company $ 126 $ 126 $ 126 $ (252) $ 126 Three months ended September 30, 2017 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ 126 $ 126 $ 133 $ (252) $ 133 Other comprehensive income, net 12 12 20 (24) 20 Total comprehensive income 138 138 153 (276) 153 Comprehensive income attributable to noncontrolling interests (8) (8) Comprehensive income attributable to the Company $ 138 $ 138 $ 145 $ (276) $ 145 Three months ended September 30, 2016 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ 1,712 $ — $ 1,712 Cost of goods sold (1,376) (1,376) Gross profit — — 336 — 336 Selling and administrative expense (121) (121) Research, development and engineering expense (16) (16) Net intercompany interest 5 (5) — Interest expense, net (5) (61) (66) Equity earnings from subsidiaries 108 108 (216) — Other equity earnings 15 15 Other expense, net 5 5 Earnings before income taxes 108 108 153 (216) 153 Provision for income taxes (36) (36) Earnings from continuing operations 108 108 117 (216) 117 Loss from discontinued operations (3) (3) Net earnings 108 108 114 (216) 114 Net (earnings) attributable to noncontrolling interests (6) (6) Net earnings attributable to the Company $ 108 $ 108 $ 108 $ (216) $ 108 Three months ended September 30, 2016 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ 108 $ 108 $ 114 $ (216) $ 114 Other comprehensive loss, net (63) (63) (59) 126 (59) Total comprehensive income 45 45 55 (90) 55 Comprehensive income attributable to noncontrolling interests (4) (4) Comprehensive income attributable to the Company $ 45 $ 45 $ 51 $ (90) $ 51 Nine months ended September 30, 2017 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ 5,157 $ — $ 5,157 Cost of goods sold (4,143) (4,143) Gross profit — — 1,014 — 1,014 Selling and administrative expense (362) (362) Research, development and engineering expense (46) (46) Net intercompany interest 21 (21) — Interest expense, net (21) (183) (204) Equity earnings from subsidiaries 314 314 (628) — Other equity earnings 55 55 Other expense, net (61) (61) Earnings before income taxes 314 314 396 (628) 396 Provision for income taxes (65) (65) Earnings from continuing operations 314 314 331 (628) 331 Loss from discontinued operations (2) (2) Net earnings 314 314 329 (628) 329 Net (earnings) attributable to noncontrolling interests (15) (15) Net earnings attributable to the Company $ 314 $ 314 $ 314 $ (628) $ 314 Nine months ended September 30, 2017 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ 314 $ 314 $ 329 $ (628) $ 329 Other comprehensive income, net 219 219 227 (438) 227 Total comprehensive income 533 533 556 (1,066) 556 Comprehensive income attributable to noncontrolling interests (8) (8) Comprehensive income attributable to the Company $ 533 $ 533 $ 548 $ (1,066) $ 548 Nine months ended September 30, 2016 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ 5,060 $ — $ 5,060 Cost of goods sold (4,063) (4,063) Gross profit — — 997 — 997 Selling and administrative expense (375) (375) Research, development and engineering expense (48) (48) Net intercompany interest 15 (15) — Interest expense, net (15) (184) (199) Equity earnings from subsidiaries 280 280 (560) — Other equity earnings 44 44 Other expense, net (24) (24) Earnings before income taxes 280 280 395 (560) 395 Provision for income taxes (93) (93) Earnings from continuing operations 280 280 302 (560) 302 Loss from discontinued operations (6) (6) Net earnings 280 280 296 (560) 296 Net (earnings) attributable to noncontrolling interests (16) (16) Net earnings attributable to the Company $ 280 $ 280 $ 280 $ (560) $ 280 Nine months ended September 30, 2016 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ 280 $ 280 $ 296 $ (560) $ 296 Other comprehensive loss, net (89) (89) (83) 178 (83) Total comprehensive income 191 191 213 (382) 213 Comprehensive income attributable to noncontrolling interests (6) (6) Comprehensive income attributable to the Company $ 191 $ 191 $ 207 $ (382) $ 207
Cash Flows	Nine months ended September 30, 2017 Non- Guarantor Guarantor Cash Flows Parent Subsidiaries Subsidiaries Eliminations Consolidated Cash provided by (utilized in) operating activities $ (50) $ — 87 $ — $ 37 Cash utilized in investing activities (200) (200) Cash provided by (utilized in) financing activities 50 (64) (14) Effect of exchange rate change on cash 24 24 Net change in cash — — (153) — (153) Cash at beginning of period 492 492 Cash at end of period $ — $ — $ 339 $ — $ 339 Nine months ended September 30, 2016 Non- Guarantor Guarantor Cash Flows Parent Subsidiaries Subsidiaries Eliminations Consolidated Cash utilized in operating activities $ (45) $ — $ 265 $ — $ 220 Cash utilized in investing activities (282) (282) Cash provided by financing activities 45 (84) (39) Effect of exchange rate change on cash (4) (4) Net change in cash — — (105) — (105) Cash at beginning of period 399 399 Cash at end of period $ — $ — $ 294 $ — $ 294

Segment Information - Reportabl

Segment Information - Reportable Segments (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2017USD ($)item	Sep. 30, 2016USD ($)
Segment Reporting Information
Number of reportable segments | item			4
Net sales:
Net sales	$ 1,791	$ 1,712	$ 5,157	$ 5,060
Items excluded from Segment Operating Profit:
Retained corporate costs and other	(25)	(18)	(81)	(75)
Restructuring, asset impairment and other			(49)	(12)
Interest expense, net
Interest expense, net	(63)	(66)	(204)	(199)
Earnings from continuing operations before income taxes
Earnings from continuing operations before income taxes	172	153	396	395
Reportable Segment Totals
Net sales:
Net sales	1,775	1,699	5,103	5,013
Segment operating profit:
Segment operating profit	260	237	730	681
Europe
Net sales:
Net sales	624	586	1,813	1,795
Segment operating profit:
Segment operating profit	81	64	220	192
North America
Net sales:
Net sales	551	578	1,651	1,709
Segment operating profit:
Segment operating profit	75	79	252	247
Latin America
Net sales:
Net sales	412	365	1,123	1,022
Segment operating profit:
Segment operating profit	84	74	207	194
Latin America | Intercompany sales
Net sales:
Net sales	34	36	97	129
Asia Pacific
Net sales:
Net sales	188	170	516	487
Segment operating profit:
Segment operating profit	20	20	51	48
Other
Net sales:
Net sales	$ 16	$ 13	$ 54	$ 47

Segment Information - Total Ass

Segment Information - Total Assets (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016
Assets
Total assets:	$ 9,999	$ 9,135	$ 9,497
Reportable Segment Totals
Assets
Total assets:	9,784	8,777	9,162
Europe
Assets
Total assets:	3,140	2,792	2,972
North America
Assets
Total assets:	2,826	2,522	2,536
Latin America
Assets
Total assets:	2,772	2,537	2,629
Asia Pacific
Assets
Total assets:	1,046	926	1,025
Other
Assets
Total assets:	$ 215	$ 358	$ 335

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016
Inventories
Finished goods	$ 875	$ 827	$ 892
Raw materials	129	118	127
Operating supplies	42	38	38
Inventories	$ 1,046	$ 983	$ 1,057

Prepaid Expenses and Other Cu40

Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016
Prepaid expenses and other current assets:
Prepaid expenses	$ 50	$ 50	$ 61
Value added taxes	44	46	42
Other	160	103	131
Prepaid expenses and other current assets	$ 254	$ 199	$ 234

Derivative Instruments - Deriva

Derivative Instruments - Derivatives and Hedges (Details) € in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)MMBTU	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)MMBTU	Sep. 30, 2017EUR (€)MMBTU	Sep. 30, 2017USD ($)MMBTU	Dec. 31, 2016USD ($)
Commodity forwards contracts | Cash Flow Hedges
Derivatives and Hedges
Coverage of commodity forward contracts (in MM BTUs) | MMBTU		12,400,000		12,400,000	9,300,000	9,300,000
Unrecognized (loss) gain included in Accumulated OCI		$ 2		$ 2		$ (1)	$ 6
Commodity forward contracts gain (loss) recognized in OCI	$ (1)	(1)	$ 3	2
Foreign exchange contracts | Derivatives not designated as hedging instruments | Other Expense
Derivatives and Hedges
Foreign exchange contracts gain (loss) recognized in income	$ (2)	4	$ 4	6
Forward exchange contracts | Derivatives not designated as hedging instruments
Derivatives and Hedges
Notional amount		$ 580		$ 580		320
Cross-currency interest rate swap | Cash Flow Hedges
Derivatives and Hedges
Notional amount					€ 81	$ 90
Interest Rate Swaps | Derivatives designated as hedging instruments
Derivatives and Hedges
Notional amount | €					€ 400

Derivative Instruments - Balanc

Derivative Instruments - Balance Sheet Classification (Details) € in Millions, $ in Millions	Sep. 30, 2017EUR (€)	Sep. 30, 2017USD ($)	Mar. 31, 2017	Dec. 31, 2016USD ($)	Nov. 30, 2016	Sep. 30, 2016USD ($)
Derivatives, Fair Value
Total asset derivatives		$ 5		$ 15		$ 10
Total liability derivatives		$ 9		5		2
Senior Notes 3.125%, due 2024 (725 million EUR at September 30,2017 and 500 million EUR at December 31,2016)
Derivatives, Fair Value
Amount Hedged | €	€ 400
Receive Rate	3.125%	3.125%	3.125%		3.125%
Average Spread	2.50%	2.50%
Derivatives not designated as hedging instruments | Foreign exchange contracts | Receivables.
Derivatives, Fair Value
Total asset derivatives		$ 2		9		8
Derivatives not designated as hedging instruments | Foreign exchange contracts | Other liabilities (current)
Derivatives, Fair Value
Total liability derivatives		3		5		2
Derivatives designated as hedging instruments | Commodity futures contracts | Other assets.
Derivatives, Fair Value
Total asset derivatives		1		$ 6		$ 2
Derivatives designated as hedging instruments | Commodity futures contracts | Other liabilities (current)
Derivatives, Fair Value
Total liability derivatives		1
Derivatives designated as hedging instruments | Interest Rate Swaps | Receivables.
Derivatives, Fair Value
Total asset derivatives		2
Derivatives designated as hedging instruments | Interest Rate Swaps | Other liabilities (noncurrent)
Derivatives, Fair Value
Total liability derivatives		$ 5

Restructuring Accruals (Details

Restructuring Accruals (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Restructuring accrual
Beginning balance, restructuring reserve		$ 34		$ 43
Charges			$ 48	19
Write-down of assets to net realizable value				(7)
Net cash paid, principally severance and related benefits		(3)	(30)	(20)
Other, including foreign exchange translation		(2)		(6)
Ending balance, restructuring reserve		29		29
Asia Pacific Restructuring
Restructuring accrual
Beginning balance, restructuring reserve		6		7
Charges				1
Net cash paid, principally severance and related benefits		(1)		(2)
Other, including foreign exchange translation				(1)
Ending balance, restructuring reserve		5		5
Restructuring, Additional Information
Cumulative employee costs and asset impairments				224
Other Restructuring Actions
Restructuring accrual
Beginning balance, restructuring reserve	$ 111	28	85	36
Charges			48	18
Write-down of assets to net realizable value			(9)	(7)
Net cash paid, principally severance and related benefits	(14)	(2)	(30)	(18)
Other, including foreign exchange translation	1	(2)	4	(5)
Ending balance, restructuring reserve	$ 98	$ 24	98	24
Restructuring, Additional Information
Other restructuring costs				1
Other Restructuring Actions | Latin America
Restructuring, Additional Information
Employee costs, asset impairments and other exit costs			33	14
Other Restructuring Actions | Europe
Restructuring, Additional Information
Cumulative plant closure costs			54
Employee costs, asset impairments and other exit costs			13
Other Restructuring Actions | North America
Restructuring, Additional Information
Employee costs, asset impairments and other exit costs			$ 2
Employee and other exit costs				$ 3

Pension Benefit Plans (Details)

Pension Benefit Plans (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
U.S Pension Plans
Components of net periodic pension cost
Service cost		$ 4	$ 3	$ 11	$ 11
Interest cost		20	23	59	72
Expected asset return		(33)	(37)	(98)	(113)
Amortization:
Actuarial loss		14	16	44	47
Net periodic pension cost		5	5	16	17
Increase in pension liability	$ 60
Non-U.S. Pension Plans
Components of net periodic pension cost
Service cost		4	4	12	13
Interest cost		11	12	33	38
Expected asset return		(18)	(19)	(54)	(61)
Amortization:
Actuarial loss		5	5	15	15
Net periodic pension cost		$ 2	$ 2	$ 6	$ 5

Income Taxes (Details)

Income Taxes (Details)	9 Months Ended
	Sep. 30, 2017
Income Taxes
Statutory U.S. Federal tax rate (as a percent)	35.00%

Debt (Details)

Debt (Details) $ / shares in Units, € in Millions, $ in Millions	1 Months Ended			9 Months Ended
	Mar. 31, 2017USD ($)	Nov. 30, 2016USD ($)	Aug. 31, 2015USD ($)	Sep. 30, 2017USD ($)item	Sep. 30, 2017EUR (€)	Sep. 30, 2017USD ($)$ / shares	Mar. 31, 2017EUR (€)	Mar. 31, 2017USD ($)	Dec. 31, 2016EUR (€)	Dec. 31, 2016USD ($)	Nov. 30, 2016EUR (€)	Sep. 30, 2016USD ($)	Feb. 03, 2016
Debt Instrument
Total long-term debt						$ 5,426				$ 5,166		$ 5,409
Less amounts due within one year						48				33		76
Long-term debt						5,378				5,133		5,333
Accounts receivable securitization
Short-term loans and long-term debt due within one year						243				195		262
Fair values of fixed rate debt obligations
Interest charges for note repurchase premiums and related write-off of unamortized finance fees	$ 17
New Agreement
Debt Instrument
Leverage ratio, period one													4.50%
Leverage ratio, period two													4.00%
Unused Credit						$ 652
Number financial maintenance covenants | item				1
Accounts receivable securitization
Weighted average interest rate, short-term debt (as a percent)					2.57%	2.57%
Revolving Loans
Debt Instrument
Total long-term debt						$ 200
Term Loan A
Debt Instrument
Total long-term debt						1,202				1,395		1,516
Face Value						1,575
Net proceeds, after deducting debt issuance costs				$ 1,202
Term Loan A (279 million EUR)
Debt Instrument
Total long-term debt					€ 279	308				282		303
Net proceeds, after deducting debt issuance costs				$ 308
Term Loan B
Debt Instrument
Total long-term debt												558
Senior Notes 6.75%, due 2020 (500 million EUR)
Debt Instrument
Total long-term debt					€ 500	$ 586				523		557
Interest rate, stated percentage					6.75%	6.75%
Fair values of fixed rate debt obligations
Principal Amount						$ 589
Indicated Market Price (in dollars per share) | $ / shares						$ 118.38
Fair Value						$ 697
Senior Notes 4.875%, due 2021 (330 million EUR)
Debt Instrument
Total long-term debt					€ 330	$ 386				345		367
Interest rate, stated percentage					4.875%	4.875%
Fair values of fixed rate debt obligations
Principal Amount						$ 389
Indicated Market Price (in dollars per share) | $ / shares						$ 113.85
Fair Value						$ 443
Senior Notes 5.00%, due 2022
Debt Instrument
Total long-term debt						$ 496				495		495
Interest rate, stated percentage					5.00%	5.00%
Fair values of fixed rate debt obligations
Principal Amount						$ 500
Indicated Market Price (in dollars per share) | $ / shares						$ 105.80
Fair Value						$ 529
Senior Notes 5.875%, due 2023
Debt Instrument
Total long-term debt						$ 684				682		681
Interest rate, stated percentage			5.875%		5.875%	5.875%
Face Value			$ 700
Fair values of fixed rate debt obligations
Principal Amount						$ 700
Indicated Market Price (in dollars per share) | $ / shares						$ 110.65
Fair Value						$ 775
Senior Notes 3.125%, due 2024 (725 million EUR at September 30,2017 and 500 million EUR at December 31,2016)
Debt Instrument
Total long-term debt					€ 725	$ 840			€ 500	520
Interest rate, stated percentage					3.125%	3.125%	3.125%	3.125%			3.125%
Face Value | €							€ 225				€ 500
Net proceeds, after deducting debt issuance costs	$ 237	$ 520
Fair values of fixed rate debt obligations
Principal Amount						$ 854
Indicated Market Price (in dollars per share) | $ / shares						$ 103.38
Fair Value						$ 883
Senior Notes, 5.375% due 2025
Debt Instrument
Total long-term debt						$ 295				294		294
Interest rate, stated percentage					6.375%	6.375%
Fair values of fixed rate debt obligations
Principal Amount						$ 300
Indicated Market Price (in dollars per share) | $ / shares						$ 106.98
Fair Value						$ 321
Senior Notes 6.375%, due 2025
Debt Instrument
Total long-term debt						$ 297				297		296
Interest rate, stated percentage			6.375%		5.375%	5.375%
Face Value			$ 300
Net proceeds, after deducting debt issuance costs			$ 972
Fair values of fixed rate debt obligations
Principal Amount						$ 300
Indicated Market Price (in dollars per share) | $ / shares						$ 113.10
Fair Value						$ 339
Senior Debentures 7.80%, due 2018
Debt Instrument
Total long-term debt						22				250		250
Long-term debt						$ 22
Interest rate, stated percentage					7.80%	7.80%	7.80%	7.80%
Face Value								$ 228
Fair values of fixed rate debt obligations
Principal Amount						$ 22
Indicated Market Price (in dollars per share) | $ / shares						$ 103.77
Fair Value						$ 23
Capital leases
Debt Instrument
Total long-term debt						54				57		62
Other debt
Debt Instrument
Total long-term debt						56				26		30
Revolving Credit Facility | New Agreement
Debt Instrument
Total long-term debt						300
Multicurrency Revolving Credit Facility | New Agreement
Debt Instrument
Total long-term debt						600
Accounts Receivable Securitization Program
Accounts receivable securitization
Short-term loans and long-term debt due within one year						$ 170				$ 152		$ 158
Weighted average interest rate, short-term debt (as a percent)					0.65%	0.65%			0.74%	0.74%		0.67%
European Accounts Receivable Securitization Program
Accounts receivable securitization
Maximum Borrowing Capacity | €					€ 185
Parent
Debt Instrument
Long-term debt										$ 250		$ 250
Accounts receivable securitization
Short-term loans and long-term debt due within one year						$ 22
Minimum | Secured Credit Agreement
Debt Instrument
Interest rate margin, Eurocurrency Rate loans (as a percent)					1.25%	1.25%
Interest rate margin, Base Rate loans (as a percent)				0.25%
Minimum | Revolving Credit Facility
Debt Instrument
Facility fee payable (as a percent)				0.20%
Maximum | Secured Credit Agreement
Debt Instrument
Interest rate margin, Eurocurrency Rate loans (as a percent)					1.75%	1.75%
Interest rate margin, Base Rate loans (as a percent)				0.75%
Maximum | Revolving Credit Facility
Debt Instrument
Facility fee payable (as a percent)				0.30%

Contingencies - Asbestos (Detai

Contingencies - Asbestos (Details)	9 Months Ended		12 Months Ended
	Sep. 30, 2017USD ($)item	Sep. 30, 2016USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 1993USD ($)
Asbestos
Sale of goods containing asbestos from 1948 to 1958	$ 40,000,000
Number of pending plaintiffs and claimants | item	1,400
Period in which significant majority of claims to be received	10 years
Approximate number of claims disposed of to date | item	399,000
Average indemnity payment per claim	$ 9,500
Payments for Asbestos-Related Liabilities	49,000,000	$ 45,000,000	$ 125,000,000	$ 138,000,000	$ 148,000,000
Cash payments per claim disposed including legal costs			71,000	95,000	81,000
Asbestos-related liability, total amount accrued beginning in 1993 through 2016 before insurance recoveries	$ 4,900,000,000					$ 975,000,000
Accrual of asbestos related liability			692,000,000	817,000,000
Asbestos related charges			0	$ 16,000,000	$ 46,000,000
Maximum
Asbestos
Loss contingency, plaintiffs damages			$ 825,000,000
Damages unspecified or sufficient to invoke jurisdictional minimum
Asbestos
Percentage of asbestos plaintiffs, approximate percentage			88.00%
Damages of $15 million or less
Asbestos
Percentage of asbestos plaintiffs, approximate percentage			9.00%
Damages of $15 million or less | Minimum
Asbestos
Loss contingency, plaintiffs damages			$ 15,000,000
Damages greater than $15 million but less than $100 million
Asbestos
Percentage of asbestos plaintiffs, approximate percentage			3.00%
Damages greater than $15 million but less than $100 million | Minimum
Asbestos
Loss contingency, plaintiffs damages			$ 15,000,000
Damages greater than $15 million but less than $100 million | Maximum
Asbestos
Loss contingency, plaintiffs damages			$ 100,000,000

Share Owners' Equity (Details)

Share Owners' Equity (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Increase (Decrease) in Share Owners' Equity
Balance	$ 779	$ 458	$ 363	$ 279
Issuance of common stock				$ 5
Issuance of common stock (in shares)				505,471
Reissuance of common stock	$ 2	$ 3	$ 7	$ 10
Reissuance of common stock (in shares)	85,290	114,039	286,455	297,875
Stock compensation	$ 5		$ 13	$ 9
Net earnings	133	$ 114	329	296
Other comprehensive income (loss)	20	(59)	227	(83)
Acquisitions of noncontrolling interest		(1)		(1)
Balance	$ 939	$ 515	$ 939	$ 515
Common Stock, Number of Shares, Par Value and Other Disclosures
Common stock, shares authorized	250,000,000		250,000,000
Common stock, par value (in dollars per share)	$ 0.01		$ 0.01
Shares of common stock issued (including treasury shares)	185,722,000	185,418,000	185,722,000	185,418,000	185,355,000
Treasury stock, shares	22,731,000	23,221,000	22,731,000	23,221,000	23,017,000
Common Stock
Increase (Decrease) in Share Owners' Equity
Balance	$ 2	$ 2	$ 2	$ 2
Balance	2	2	2	2
Capital in Excess of Par Value
Increase (Decrease) in Share Owners' Equity
Balance	3,088	3,078	3,080	3,064
Issuance of common stock				5
Stock compensation	5		13	9
Acquisitions of noncontrolling interest		(1)		(1)
Balance	3,093	3,077	3,093	3,077
Treasury Stock
Increase (Decrease) in Share Owners' Equity
Balance	(555)	(566)	(560)	(573)
Reissuance of common stock	2	3	7	10
Balance	(553)	(563)	(553)	(563)
Retained Earnings (Loss)
Increase (Decrease) in Share Owners' Equity
Balance	92	(133)	(96)	(305)
Net earnings	126	108	314	280
Balance	218	(25)	218	(25)
Accumulated Other Comprehensive Loss.
Increase (Decrease) in Share Owners' Equity
Balance	(1,957)	(2,033)	(2,172)	(2,017)
Other comprehensive income (loss)	19	(57)	234	(73)
Balance	(1,938)	(2,090)	(1,938)	(2,090)
Non-controlling Interests
Increase (Decrease) in Share Owners' Equity
Balance	109	110	109	108
Net earnings	7	6	15	16
Other comprehensive income (loss)	1	(2)	(7)	(10)
Balance	$ 117	$ 114	$ 117	$ 114

Accumulated Other Comprehensi49

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance	$ 779	$ 458	$ 363	$ 279
Other comprehensive income (loss)	20	(59)	227	(83)
Balance	939	515	939	515
Net Effect of Exchange Rate Fluctuations
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance	(578)	(574)	(788)	(568)
Change before reclassifications	9	(77)	219	(83)
Other comprehensive income (loss)	9	(77)	219	(83)
Balance	(569)	(651)	(569)	(651)
Change in Certain Derivative Instruments
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance	(14)	(11)	(4)	(17)
Amounts reclassified from accumulated other comprehensive income		(1)	(10)	4
Tax effect				1
Other comprehensive income (loss)		(1)	(10)	5
Balance	(14)	(12)	(14)	(12)
Employee Benefit Plans
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance	(1,365)	(1,448)	(1,380)	(1,432)
Change before reclassifications	(2)		(12)
Amounts reclassified from accumulated other comprehensive income	19	26	58	(2)
Translation effect	(7)	(5)	(21)	6
Tax effect				1
Other comprehensive income (loss)	10	21	25	5
Balance	(1,355)	(1,427)	(1,355)	(1,427)
Accumulated Other Comprehensive Loss.
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance	(1,957)	(2,033)	(2,172)	(2,017)
Change before reclassifications	7	(77)	207	(83)
Amounts reclassified from accumulated other comprehensive income	19	25	48	2
Translation effect	(7)	(5)	(21)	6
Tax effect				2
Other comprehensive income (loss)	19	(57)	234	(73)
Balance	$ (1,938)	$ (2,090)	$ (1,938)	$ (2,090)

Other Expense (Income), net (De

Other Expense (Income), net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Other Expense (Income), net
Restructuring, asset impairment and other charges			$ 49	$ 19
Gain on sale of land in China				(7)
Foreign currency exchange loss (gain)	$ 3	$ 2	3	6
Intangible amortization expense	11	10	31	30
Royalty income	(4)	(4)	(11)	(9)
Other income	(5)	(13)	(11)	(15)
Other Expense (Income), net	$ 5	$ (5)	$ 61	$ 24

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Numerator:
Net earnings attributable to the Company	$ 126	$ 108	$ 314	$ 280
Denominator (in thousands):
Denominator for basic earnings per share - weighted average shares outstanding (in shares)	162,866,000	162,080,000	162,658,000	161,744,000
Effect of dilutive securities:
Stock options and other (in shares)	2,127,000	1,124,000	1,782,000	863,000
Denominator for diluted earnings per share - adjusted weighted average shares outstanding (in shares)	164,993,000	163,204,000	164,440,000	162,607,000
Basic earnings per share:
Earnings from continuing operations (in dollars per share)	$ 0.78	$ 0.68	$ 1.94	$ 1.76
Loss from discontinued operations (in dollars per share)	(0.01)	(0.02)	(0.01)	(0.04)
Net earnings (in dollars per share)	0.77	0.66	1.93	1.72
Diluted earnings per share:
Earnings from continuing operations (in dollars per share)	0.77	0.68	1.92	1.75
Loss from discontinued operations (in dollars per share)	(0.01)	(0.02)	(0.01)	(0.04)
Net earnings (in dollars per share)	$ 0.76	$ 0.66	$ 1.91	$ 1.71
Weighted average shares of common stock attributable to options not included in diluted earnings per share (in shares)	1,168,671	2,858,371	1,664,845	2,922,833

Supplemental Cash Flow Inform52

Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Supplemental Cash Flow Information
Interest paid in cash	$ 209	$ 214
Income taxes paid in cash (all non-US)	120	93
Interest paid for note repurchase premiums related to debt repaid prior to maturity	16
Amount of receivables sold	$ 145	$ 240

Discontinued Operations (Detail

Discontinued Operations (Details) $ in Millions	Jul. 31, 2017USD ($)	Apr. 04, 2016Plant	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)
Subsidiaries
Loss from discontinued operations			$ (2)	$ (3)	$ (2)	$ (6)
OI European Group B.V. (“OIEG”)
Subsidiaries
Litigation Settlement, Amount	$ 115
Minimum | OI European Group B.V. (“OIEG”)
Subsidiaries
Litigation Settlement, Amount					500
Disposed Venezuelan subsidiaries
Subsidiaries
Expropriated plants | Plant		2
Disposed Venezuelan subsidiaries | Maximum | Discontinued Operations, Disposed of by Means Other than Sale
Subsidiaries
Loss from discontinued operations					$ 2	$ 6

New Accounting Pronouncement (D

New Accounting Pronouncement (Details) $ in Millions	Dec. 31, 2016USD ($)
New Accounting Pronouncement
Minimum lease commitments under non-cancellable operating leases	$ 205

Financial Information for Sub55

Financial Information for Subsidiary Guarantors and Non-Guarantors - Balance Sheet (Details) $ in Millions	9 Months Ended
	Sep. 30, 2017USD ($)item	Dec. 31, 2016USD ($)	Sep. 30, 2016USD ($)
Financial Information for Subsidiary Guarantors and Non Guarantors
Number of subsidiaries that have guaranteed the notes | item	2
Ownership percentage in Guarantor Subsidiaries	100.00%
Current assets:
Cash and cash equivalents	$ 339	$ 492	$ 294
Trade receivables, net	1,028	580	857
Inventories	1,046	983	1,057
Prepaid expenses and other current assets	254	199	234
Total current assets	2,667	2,254	2,442
Property, plant and equipment, net	3,036	2,880	2,917
Goodwill	2,621	2,462	2,534
Intangibles, net	473	464	490
Other assets	1,202	1,075	1,114
Total assets	9,999	9,135	9,497
Current liabilities:
Short-term loans and long-term debt due within one year	243	195	262
Current portion of asbestos liability	115	115	130
Accounts payable	1,087	1,135	1,059
Other liabilities	617	615	582
Other liabilities - discontinued operations	115
Total current liabilities	2,177	2,060	2,033
Long-term debt	5,378	5,133	5,333
Asbestos-related liabilities	528	577	643
Other long-term liabilities	977	1,002	973
Share owners’ equity	822	254	401
Noncontrolling interests	117	109	114
Total liabilities and share owners' equity	9,999	9,135	9,497
Eliminations
Current assets:
Investments in and advances to subsidiaries	(2,953)	(2,144)	(2,605)
Total assets	(2,953)	(2,144)	(2,605)
Current liabilities:
Short-term loans and long-term debt due within one year	(22)
Other liabilities	(1)	(2)	(7)
Total current liabilities	(23)	(2)	(7)
Long-term debt		(250)	(250)
Share owners’ equity	(2,930)	(1,892)	(2,348)
Total liabilities and share owners' equity	(2,953)	(2,144)	(2,605)
Parent
Current assets:
Investments in and advances to subsidiaries	1,488	1,198	1,431
Total assets	1,488	1,198	1,431
Current liabilities:
Short-term loans and long-term debt due within one year	22
Current portion of asbestos liability	115	115	130
Other liabilities	1	2	7
Total current liabilities	138	117	137
Long-term debt		250	250
Asbestos-related liabilities	528	577	643
Share owners’ equity	822	254	401
Total liabilities and share owners' equity	1,488	1,198	1,431
Guarantor Subsidiaries
Current assets:
Investments in and advances to subsidiaries	1,465	946	1,174
Total assets	1,465	946	1,174
Current liabilities:
Share owners’ equity	1,465	946	1,174
Total liabilities and share owners' equity	1,465	946	1,174
Non-Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	339	492	294
Trade receivables, net	1,028	580	857
Inventories	1,046	983	1,057
Prepaid expenses and other current assets	254	199	234
Total current assets	2,667	2,254	2,442
Property, plant and equipment, net	3,036	2,880	2,917
Goodwill	2,621	2,462	2,534
Intangibles, net	473	464	490
Other assets	1,202	1,075	1,114
Total assets	9,999	9,135	9,497
Current liabilities:
Short-term loans and long-term debt due within one year	243	195	262
Accounts payable	1,087	1,135	1,059
Other liabilities	617	615	582
Other liabilities - discontinued operations	115
Total current liabilities	2,062	1,945	1,903
Long-term debt	5,378	5,133	5,333
Other long-term liabilities	977	1,002	973
Share owners’ equity	1,465	946	1,174
Noncontrolling interests	117	109	114
Total liabilities and share owners' equity	$ 9,999	$ 9,135	$ 9,497

Financial Information for Sub56

Financial Information for Subsidiary Guarantors and Non-Guarantors - Results of Operations and Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Results of Operations
Net sales	$ 1,791	$ 1,712	$ 5,157	$ 5,060
Cost of goods sold	(1,438)	(1,376)	(4,143)	(4,063)
Gross profit	353	336	1,014	997
Selling and administrative expense	(120)	(121)	(362)	(375)
Research, development and engineering expense	(15)	(16)	(46)	(48)
Interest expense, net	(63)	(66)	(204)	(199)
Other equity earnings	22	15	55	44
Other expense, net	(5)	5	(61)	(24)
Earnings from continuing operations before income taxes	172	153	396	395
Provision for income taxes	(37)	(36)	(65)	(93)
Earnings from continuing operations	135	117	331	302
Loss from discontinued operations	(2)	(3)	(2)	(6)
Net earnings	133	114	329	296
Net (earnings) attributable to noncontrolling interests	(7)	(6)	(15)	(16)
Net earnings attributable to the Company	126	108	314	280
Comprehensive Income
Net earnings	133	114	329	296
Other comprehensive income (loss), net	20	(59)	227	(83)
Total comprehensive income	153	55	556	213
Comprehensive income attributable to noncontrolling interests	(8)	(4)	(8)	(6)
Comprehensive income attributable to the Company	145	51	548	207
Parent
Results of Operations
Net intercompany interest		5	21	15
Interest expense, net		(5)	(21)	(15)
Equity earnings from subsidiaries	126	108	314	280
Earnings from continuing operations before income taxes	126	108	314	280
Earnings from continuing operations	126	108	314	280
Net earnings	126	108	314	280
Net earnings attributable to the Company	126	108	314	280
Comprehensive Income
Net earnings	126	108	314	280
Other comprehensive income (loss), net	12	(63)	219	(89)
Total comprehensive income	138	45	533	191
Comprehensive income attributable to the Company	138	45	533	191
Guarantor Subsidiaries
Results of Operations
Equity earnings from subsidiaries	126	108	314	280
Earnings from continuing operations before income taxes	126	108	314	280
Earnings from continuing operations	126	108	314	280
Net earnings	126	108	314	280
Net earnings attributable to the Company	126	108	314	280
Comprehensive Income
Net earnings	126	108	314	280
Other comprehensive income (loss), net	12	(63)	219	(89)
Total comprehensive income	138	45	533	191
Comprehensive income attributable to the Company	138	45	533	191
Non-Guarantor Subsidiaries
Results of Operations
Net sales	1,791	1,712	5,157	5,060
Cost of goods sold	(1,438)	(1,376)	(4,143)	(4,063)
Gross profit	353	336	1,014	997
Selling and administrative expense	(120)	(121)	(362)	(375)
Research, development and engineering expense	(15)	(16)	(46)	(48)
Net intercompany interest		(5)	(21)	(15)
Interest expense, net	(63)	(61)	(183)	(184)
Other equity earnings	22	15	55	44
Other expense, net	(5)	5	(61)	(24)
Earnings from continuing operations before income taxes	172	153	396	395
Provision for income taxes	(37)	(36)	(65)	(93)
Earnings from continuing operations	135	117	331	302
Loss from discontinued operations	(2)	(3)	(2)	(6)
Net earnings	133	114	329	296
Net (earnings) attributable to noncontrolling interests	(7)	(6)	(15)	(16)
Net earnings attributable to the Company	126	108	314	280
Comprehensive Income
Net earnings	133	114	329	296
Other comprehensive income (loss), net	20	(59)	227	(83)
Total comprehensive income	153	55	556	213
Comprehensive income attributable to noncontrolling interests	(8)	(4)	(8)	(6)
Comprehensive income attributable to the Company	145	51	548	207
Eliminations
Results of Operations
Equity earnings from subsidiaries	(252)	(216)	(628)	(560)
Earnings from continuing operations before income taxes	(252)	(216)	(628)	(560)
Earnings from continuing operations	(252)	(216)	(628)	(560)
Net earnings	(252)	(216)	(628)	(560)
Net earnings attributable to the Company	(252)	(216)	(628)	(560)
Comprehensive Income
Net earnings	(252)	(216)	(628)	(560)
Other comprehensive income (loss), net	(24)	126	(438)	178
Total comprehensive income	(276)	(90)	(1,066)	(382)
Comprehensive income attributable to the Company	$ (276)	$ (90)	$ (1,066)	$ (382)

Financial Information for Sub57

Financial Information for Subsidiary Guarantors and Non-Guarantors - Cash Flows (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash Flows
Cash provided by (utilized in) operating activities	$ 37	$ 220
Cash utilized in investing activities	(200)	(282)
Cash provided by (utilized in) financing activities	(14)	(39)
Effect of exchange rate change on cash	24	(4)
Decrease in cash	(153)	(105)
Cash at beginning of period	492	399
Cash at end of period	339	294
Parent
Cash Flows
Cash provided by (utilized in) operating activities	(50)	(45)
Cash provided by (utilized in) financing activities	50	45
Non-Guarantor Subsidiaries
Cash Flows
Cash provided by (utilized in) operating activities	87	265
Cash utilized in investing activities	(200)	(282)
Cash provided by (utilized in) financing activities	(64)	(84)
Effect of exchange rate change on cash	24	(4)
Decrease in cash	(153)	(105)
Cash at beginning of period	492	399
Cash at end of period	$ 339	$ 294